{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":224,"total_is_capped":false,"direct_labels_cover":1,"predictions_cover":224,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"2390c1d24952","filters":{"venue":"Antiviral Research"}},"results":[{"id":"W3005409321","doi":"10.1016/j.antiviral.2020.104742","title":"The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade","year":2020,"lang":"en","type":"article","venue":"Antiviral Research","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":1837,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"Horizon 2020; Canadian Institutes of Health Research","keywords":"Furin; Virology; Coronavirus; Biology; Genome; Cleavage (geology); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Glycoprotein; Coronavirus disease 2019 (COVID-19); Betacoronavirus; Pandemic; Genetics; Clade; Computational biology; Gene; Phylogenetic tree; Infectious disease (medical specialty); Medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.1104997214578096,"gpt":0.4100366145346238,"spread":0.2995368930768141,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001484894,0.0002099883,0.0004604841,0.0001345101,0.0002529065,0.00005664544,0.001221079,0.0001644663,0.00001251591],"category_scores_gemma":[0.00165743,0.0001078459,0.0002890687,0.001602877,0.0009841816,0.0000928526,0.001084552,0.001678624,0.0001790507],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001836619,"about_ca_system_score_gemma":0.001716447,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01111454,"about_ca_topic_score_gemma":0.004336759,"domain_scores_codex":[0.9950374,0.0008146564,0.0005654965,0.0004467307,0.002264788,0.0008709413],"domain_scores_gemma":[0.9974969,0.0009165838,0.0001413027,0.001084886,0.0002939647,0.00006635958],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002832246,0.0002302513,0.1066769,0.0001926206,0.00007334563,0.00008618485,0.001791753,2.944099e-7,0.8629519,0.001196848,0.01008497,0.0138826],"study_design_scores_gemma":[0.002568394,0.0008269674,0.1772411,0.000299324,0.00001523348,0.000006835736,0.0006297762,0.0002136526,0.7367215,0.0004141908,0.08093864,0.0001244259],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9771473,0.001150306,0.00001144123,0.0155498,0.0001087667,0.002004176,0.00003788764,0.00001789638,0.003972433],"genre_scores_gemma":[0.9899626,0.0001044857,0.00001498964,0.008583468,0.0001832327,0.00003672699,0.000001366293,0.00003821585,0.001074929],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1262305,"threshold_uncertainty_score":0.9954705,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2092528857","doi":"10.1016/j.antiviral.2013.03.014","title":"Influenza virus resistance to neuraminidase inhibitors","year":2013,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":342,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre hospitalier de l'Université Laval; Université Laval","funders":"","keywords":"Zanamivir; Neuraminidase; Neuraminidase inhibitor; Oseltamivir; Medicine; Antiviral drug; Drug resistance; Pandemic; Virus; Virology; Drug; Intensive care medicine; Pharmacology; Biology; Coronavirus disease 2019 (COVID-19); Microbiology; Infectious disease (medical specialty); Disease; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.4169960621239613,"gpt":0.5538126083726812,"spread":0.1368165462487199,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003317009,0.0008676017,0.003085459,0.002398588,0.0006004813,0.0003239273,0.0009949522,0.0006682886,0.0001534733],"category_scores_gemma":[0.00813411,0.0006408494,0.0007795657,0.003828817,0.0008661763,0.0003012976,0.001786936,0.004052336,0.02266073],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008454418,"about_ca_system_score_gemma":0.00179116,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000310253,"about_ca_topic_score_gemma":0.00008883908,"domain_scores_codex":[0.989699,0.00137804,0.001313966,0.001478817,0.003643581,0.002486611],"domain_scores_gemma":[0.9938641,0.001822269,0.0001923055,0.001868327,0.001620921,0.0006321269],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001636939,0.0001756708,0.00002862263,0.02072401,0.0003260155,0.0005073764,0.0001434239,1.549611e-8,0.0002001794,0.0001773597,0.1646981,0.8128555],"study_design_scores_gemma":[0.0004250062,0.0004968536,0.00004792466,0.01953906,0.0001646613,0.00001133233,0.00005823494,6.108917e-7,0.0004346184,0.00003820271,0.9782597,0.0005237914],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004405075,0.9689633,0.000001259709,0.0003084728,0.000194047,0.006108376,0.0001365613,0.0001436872,0.02370383],"genre_scores_gemma":[0.0000649916,0.9662065,0.0002929662,0.0004516276,0.0009400315,0.001750506,0.00004304299,0.0002268162,0.03002355],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8135616,"threshold_uncertainty_score":0.9996043,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1971489080","doi":"10.1016/s0166-3542(02)00212-7","title":"Inhibition of adenovirus infection and adenain by green tea catechins","year":2003,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Tea Polyphenols and Effects","field":"Medicine","cited_by":225,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Virus; Epigallocatechin gallate; IC50; Green tea extract; Catechin; Titer; Proteases; Virology; Cell culture; Green tea; Chemistry; Biology; Molecular biology; Polyphenol; In vitro; Biochemistry; Antioxidant; Food science; Enzyme","retraction":null,"screen_n_in":null,"score":{"opus":0.05105207776088401,"gpt":0.370366383085422,"spread":0.319314305324538,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008878806,0.00007761329,0.0001608592,0.0001898604,0.00008927468,0.00001402448,0.00002252075,0.0000976864,0.00001884818],"category_scores_gemma":[0.0003530279,0.00006503153,0.00003235378,0.0003639615,0.0001778083,0.0001025693,0.00003401551,0.0003396405,0.00004040017],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003772861,"about_ca_system_score_gemma":0.00006372792,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002754273,"about_ca_topic_score_gemma":0.00008841876,"domain_scores_codex":[0.9988106,0.0002124002,0.0001323542,0.0001857293,0.000378656,0.0002802221],"domain_scores_gemma":[0.99957,0.00009852117,0.00002761544,0.0001487812,0.00009462858,0.00006052751],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001059107,0.0001863147,0.07443748,0.0002126526,0.00002206215,0.00002418941,0.0002755725,3.16221e-8,0.8958412,0.001407837,0.00556989,0.0219169],"study_design_scores_gemma":[0.001392191,0.001337643,0.09006526,0.0001769871,0.00001966811,0.00003497613,0.0001093325,0.00003549817,0.9011192,0.0009165621,0.004679749,0.0001129782],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9911642,0.0004687879,0.00005247568,0.0003322432,0.00002657471,0.0003023698,0.000007551341,0.00002361492,0.007622193],"genre_scores_gemma":[0.9981846,0.0002293229,0.00004132509,0.00003497483,0.00004017762,0.00001131435,0.00001139147,0.00001445124,0.001432396],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02180392,"threshold_uncertainty_score":0.4163656,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1973211512","doi":"10.1016/s0166-3542(03)00153-0","title":"Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by ribavirin and immune serum globulin in vitro","year":2003,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Respiratory viral infections research","field":"Medicine","cited_by":219,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; U.S. Department of Agriculture","keywords":"Human metapneumovirus; Ribavirin; Virology; Pneumovirinae; Virus; Palivizumab; Antibody; Paramyxoviridae; Metapneumovirus; Biology; Immune system; Monoclonal antibody; Immunology; Respiratory tract infections; Medicine; Respiratory system; Viral disease; Hepatitis C virus","retraction":null,"screen_n_in":null,"score":{"opus":0.1142173795220341,"gpt":0.4571606110466757,"spread":0.3429432315246416,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003291774,0.0001628059,0.0005583245,0.0005251525,0.000224787,0.00003291114,0.0001336875,0.0001722296,0.00002564713],"category_scores_gemma":[0.0009823259,0.0001258371,0.00008147029,0.001104754,0.001213324,0.00018505,0.0002443599,0.0009909788,0.00000790793],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001060955,"about_ca_system_score_gemma":0.0002009989,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008630535,"about_ca_topic_score_gemma":0.00013951,"domain_scores_codex":[0.9960302,0.001481458,0.0006801538,0.0003700154,0.0009694063,0.0004687949],"domain_scores_gemma":[0.9987571,0.0002780958,0.0001274474,0.0004739873,0.0002831544,0.00008027663],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002654183,0.0003652517,0.1362283,0.0001448342,0.00002572159,0.000009802112,0.0001173664,2.958624e-7,0.8592768,0.0006720459,0.0001888046,0.002705333],"study_design_scores_gemma":[0.00132219,0.0007801986,0.1593192,0.0001031808,0.00001333444,0.00000386132,0.0002071638,0.00003458923,0.8374753,0.0002023977,0.0004558986,0.00008269555],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9929349,0.002405953,0.000004527474,0.0001202868,0.00002795784,0.0007375703,0.00003212377,0.000009956931,0.00372671],"genre_scores_gemma":[0.9995559,0.00008639902,0.00002150984,0.00003359107,0.00001922979,0.0000290558,0.000003616679,0.00002366386,0.0002270223],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02309088,"threshold_uncertainty_score":0.513149,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2010436800","doi":"10.1016/j.antiviral.2007.10.009","title":"Treatment of yellow fever","year":2007,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Mosquito-borne diseases and control","field":"Medicine","cited_by":203,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Valeant Pharmaceuticals International","keywords":"Ribavirin; Cytokine storm; Medicine; Immunology; Immune system; Cytokine; Virology; Virus; Hepatitis C virus; Disease; Infectious disease (medical specialty); Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.3535669420986561,"gpt":0.5642778286320669,"spread":0.2107108865334108,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005090563,0.0002800036,0.001711018,0.0004825653,0.00005940354,0.00001933887,0.0001832296,0.0002676987,0.0001558218],"category_scores_gemma":[0.0001358232,0.0001791945,0.0009601005,0.0006208867,0.0002066736,0.00003109108,0.00006625537,0.0003394891,0.000540069],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002181089,"about_ca_system_score_gemma":0.0009046759,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001702851,"about_ca_topic_score_gemma":0.000008039174,"domain_scores_codex":[0.9973558,0.000226421,0.0004737297,0.0004391104,0.0008836887,0.0006212028],"domain_scores_gemma":[0.9983889,0.0004129334,0.00009899739,0.000704034,0.0002560455,0.0001390766],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008962183,0.000541137,0.00006746615,0.007108815,0.0003222227,0.0004513309,0.00001706696,1.193047e-9,0.000007852019,0.0002281199,0.001750931,0.9894154],"study_design_scores_gemma":[0.0007667368,0.00106366,0.00007659082,0.004039361,0.0006910808,0.00001774216,0.00002151892,0.000004105063,0.00003270646,0.0000145673,0.9931441,0.000127832],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001429167,0.9783102,0.000003993032,0.00004200041,0.00007232944,0.001434724,0.00005450244,0.00001683916,0.01992249],"genre_scores_gemma":[0.001992716,0.9718187,0.00002304366,0.000010581,0.0004497347,0.00009162303,0.0001243606,0.00005231268,0.02543696],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9913931,"threshold_uncertainty_score":0.7307339,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2067685971","doi":"10.1016/j.antiviral.2014.08.015","title":"Long-term safety and efficacy of microRNA-targeted therapy in chronic hepatitis C patients","year":2014,"lang":"en","type":"article","venue":"Antiviral Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":192,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Hepatocellular carcinoma; Dosing; Ribavirin; Internal medicine; Gastroenterology; Placebo; Hepatitis C virus; MiR-122; Chronic hepatitis; Hepatitis C; Virus; Immunology; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.01797055072973927,"gpt":0.3201822497339051,"spread":0.3022116990041659,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004465458,0.00008670537,0.0001206935,0.00009933595,0.00004755348,0.00001369526,0.0001367207,0.00009670157,0.000009626319],"category_scores_gemma":[0.0001695779,0.00008183842,0.00003822501,0.0001486173,0.0001753018,0.000005762059,0.0001217662,0.0001009266,0.000006803625],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003994352,"about_ca_system_score_gemma":0.00008301741,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001337583,"about_ca_topic_score_gemma":0.0002033674,"domain_scores_codex":[0.9988281,0.000262075,0.0001853015,0.0002644474,0.0001989088,0.0002611326],"domain_scores_gemma":[0.9994864,0.00004384514,0.00004536696,0.0002516021,0.0001391957,0.00003360454],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0001989027,0.00006992736,0.3902185,0.00002205106,0.00001102066,5.661165e-7,0.00001582166,0.000001003737,0.5803499,0.00001690989,0.00005402442,0.02904135],"study_design_scores_gemma":[0.001143087,0.0003708006,0.6664938,0.00002638583,9.954514e-7,1.950483e-7,7.270416e-7,0.00003693311,0.3315654,0.00001369486,0.0002906825,0.00005732402],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9984347,0.000937367,0.00006661446,0.00003017262,0.00002211115,0.0002917628,0.00001330377,0.000003075742,0.0002009448],"genre_scores_gemma":[0.9979259,0.001691466,0.0000327106,0.00001113298,0.0000638877,0.000005885941,0.0001698922,0.00001510542,0.0000839787],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2762752,"threshold_uncertainty_score":0.3337274,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2528330764","doi":"10.1016/j.antiviral.2016.09.013","title":"A chronological review of experimental infection studies of the role of wild animals and livestock in the maintenance and transmission of Crimean-Congo hemorrhagic fever virus","year":2016,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Viral Infections and Vectors","field":"Medicine","cited_by":157,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research; Oak Ridge Institute for Science and Education; National Institutes of Health","keywords":"Enzootic; Tick; Crimean–Congo hemorrhagic fever; Livestock; Transmission (telecommunications); Outbreak; Viremia; Tick-borne disease; Virology; Biology; Disease; Hyalomma; Veterinary medicine; Virus; Ecology; Medicine; Ixodidae; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.1717682286979072,"gpt":0.4778160913188743,"spread":0.3060478626209671,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001536493,0.0001788331,0.001301483,0.0001907893,0.00005583391,0.000003374189,0.0001304462,0.0001349555,0.00001679191],"category_scores_gemma":[0.0005209844,0.00007388903,0.0002421987,0.000528249,0.001024233,0.00005627448,0.0001514837,0.0004038604,0.000001112449],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004974048,"about_ca_system_score_gemma":0.0001369619,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003071825,"about_ca_topic_score_gemma":0.000009589424,"domain_scores_codex":[0.9977635,0.0007827351,0.0006347658,0.000242222,0.0003782204,0.0001985841],"domain_scores_gemma":[0.9987469,0.0004589928,0.0002782495,0.0002867685,0.0002069409,0.00002211389],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0001247361,0.000575154,0.002461344,0.08902833,0.0002213133,0.000005953942,0.000538566,6.660929e-9,0.03561235,0.0006093759,0.0002730498,0.8705498],"study_design_scores_gemma":[0.001964523,0.008841019,0.02110339,0.6858718,0.0008433013,0.0002278451,0.001149487,0.00000965388,0.06666017,0.0004446002,0.2124484,0.0004357999],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.1255249,0.8727602,0.000001256665,0.00006605896,0.00001568846,0.001169274,0.00001268936,0.000002411432,0.0004475551],"genre_scores_gemma":[0.3366824,0.6631982,0.00001076345,0.000007321234,0.00001494566,0.0000375792,8.84432e-7,0.000007793111,0.00004007345],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.870114,"threshold_uncertainty_score":0.3773831,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2090894089","doi":"10.1016/j.antiviral.2015.03.016","title":"The Herpes Simplex Virus-1 genome contains multiple clusters of repeated G-quadruplex: Implications for the antiviral activity of a G-quadruplex ligand","year":2015,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":155,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval","funders":"European Research Council; Bill and Melinda Gates Foundation","keywords":"Biology; Genome; G-quadruplex; Herpes simplex virus; Nucleic acid; DNA; Viral replication; Virology; Virus; Guanine; Genetics; Gene; Nucleotide","retraction":null,"screen_n_in":null,"score":{"opus":0.1761714675678894,"gpt":0.4379040866508697,"spread":0.2617326190829803,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00237305,0.0002028502,0.0004372607,0.000191104,0.0006825063,0.0000547553,0.0003272989,0.0001299416,0.000004126577],"category_scores_gemma":[0.001697887,0.000117232,0.0002573175,0.0008166056,0.0009059783,0.0001623372,0.0001940933,0.0003147675,0.00001964052],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001600522,"about_ca_system_score_gemma":0.000536349,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0037282,"about_ca_topic_score_gemma":0.001787001,"domain_scores_codex":[0.9976463,0.0003308632,0.0004644731,0.0003667767,0.0005507806,0.0006407477],"domain_scores_gemma":[0.9950387,0.002628886,0.0001967603,0.0009221762,0.001098788,0.0001146511],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.00715413,0.003472798,0.06104777,0.0002683567,0.00217191,0.00001893776,0.002719413,0.00002605583,0.3421016,0.003609157,0.005911706,0.5714982],"study_design_scores_gemma":[0.01197262,0.003805421,0.38376,0.0001494268,0.0003674789,0.00002301342,0.002288675,0.006299394,0.3785117,0.002064935,0.2102934,0.0004639411],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9913899,0.0003540525,0.0008057199,0.002969845,0.00007487732,0.00223129,0.0002853,0.00003634274,0.001852676],"genre_scores_gemma":[0.9978722,0.0003585627,0.000124874,0.00004637765,0.00009802563,0.0002781007,0.00003491296,0.00003931451,0.001147634],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5710343,"threshold_uncertainty_score":0.5635948,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2114506463","doi":"10.1016/j.antiviral.2009.04.009","title":"Induction of multiple pro-inflammatory cytokines by respiratory viruses and reversal by standardized Echinacea, a potent antiviral herbal extract","year":2009,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Herbal Medicine Research Studies","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Virus; Common cold; Chemokine; Proinflammatory cytokine; Virology; Echinacea (animal); Interleukin 8; Respiratory system; Secretion; Herb; Biology; Immunology; Medicine; Cytokine; Microbiology; Inflammation; Traditional medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.07492421491050086,"gpt":0.4056479455453276,"spread":0.3307237306348267,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003753877,0.0003293857,0.0007917342,0.0004729986,0.0003230899,0.00005112714,0.0002169842,0.0002368217,0.00001540066],"category_scores_gemma":[0.00415375,0.000261785,0.0001296172,0.0007486777,0.001081933,0.00045404,0.0001961475,0.001254841,0.0000188564],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000250861,"about_ca_system_score_gemma":0.0004622135,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002913531,"about_ca_topic_score_gemma":0.00002686966,"domain_scores_codex":[0.9945996,0.0007220568,0.0006394361,0.0006739539,0.00235718,0.001007735],"domain_scores_gemma":[0.9978485,0.0005434949,0.0001438211,0.0004744495,0.0007480456,0.0002417601],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002407695,0.0003847934,0.05310494,0.0002674506,0.0001161567,0.000147997,0.0003007245,4.381756e-8,0.8036271,0.00002764361,0.08022736,0.05938815],"study_design_scores_gemma":[0.01017676,0.009097739,0.10251,0.001186307,0.00008620249,0.000033351,0.001662142,0.0001418301,0.7935913,0.0001986942,0.08078817,0.0005275336],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9891306,0.004964157,0.00006394838,0.002229549,0.00007073186,0.001429092,0.0001108023,0.00008551541,0.001915569],"genre_scores_gemma":[0.9972902,0.001096805,0.0002397032,0.0002218587,0.0002618122,0.00003603688,0.00001665288,0.00004046478,0.0007964993],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05886061,"threshold_uncertainty_score":0.9999834,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1981742167","doi":"10.1016/j.antiviral.2007.06.014","title":"The phenylpropenamide derivative AT-130 blocks HBV replication at the level of viral RNA packaging","year":2007,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":152,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"Gilead Sciences","keywords":"Virology; Viral replication; Hepatitis B virus; Biology; Reverse transcriptase; Nucleoside analogue; In vitro; Nucleoside; Hepatitis B virus PRE beta; RNA; Transcription (linguistics); Virus; Hepatitis B virus DNA polymerase; Gene; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.2316583127402806,"gpt":0.4500056234932374,"spread":0.2183473107529568,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006130494,0.0001490636,0.0002577839,0.0001184313,0.001299827,0.00003074514,0.0003442262,0.00007186869,0.00003391859],"category_scores_gemma":[0.00354342,0.00008043423,0.00009936994,0.0006112487,0.001259982,0.00009158082,0.0008342137,0.0005476499,0.0002011839],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004014636,"about_ca_system_score_gemma":0.0001359922,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00250432,"about_ca_topic_score_gemma":0.007347526,"domain_scores_codex":[0.996879,0.0002953533,0.0004220254,0.0004120476,0.001233364,0.0007582177],"domain_scores_gemma":[0.9963084,0.001733501,0.0001286944,0.001060037,0.0007081161,0.00006121957],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0009841955,0.0001125957,0.2552969,0.00005889638,0.0001975523,0.00006492418,0.002531048,2.860473e-7,0.609274,0.00163648,0.03105772,0.0987853],"study_design_scores_gemma":[0.0004916419,0.0002527935,0.4062299,0.0001002253,0.00001921277,0.000009128052,0.0005424749,0.00008379766,0.5775909,0.0004124828,0.01417337,0.00009405717],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.952022,0.0007243496,0.0002070863,0.006865582,0.00005900285,0.0008651669,0.00001836515,0.00002491543,0.03921359],"genre_scores_gemma":[0.9662896,0.0006290958,0.0001249271,0.0001803238,0.0001600274,0.0000469732,0.00001083196,0.0000284314,0.03252976],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.150933,"threshold_uncertainty_score":0.9997349,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2487753465","doi":"10.1016/j.antiviral.2016.07.015","title":"MERS-CoV spike protein: Targets for vaccines and therapeutics","year":2016,"lang":"en","type":"review","venue":"Antiviral Research","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":134,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Canadian Institutes of Health Research; Chinese Academy of Sciences; National Natural Science Foundation of China","keywords":"Middle East respiratory syndrome coronavirus; Spike Protein; Virology; Middle East respiratory syndrome; Outbreak; Coronavirus; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Coronavirus disease 2019 (COVID-19); Biology; Medicine; Disease; Immunology; Infectious disease (medical specialty)","retraction":null,"screen_n_in":null,"score":{"opus":0.2381780743804344,"gpt":0.5081083494068118,"spread":0.2699302750263775,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002966509,0.0005647335,0.001861503,0.0009554072,0.000323133,0.0001648368,0.0006007,0.0006424292,0.000006976496],"category_scores_gemma":[0.0009281516,0.0003445045,0.0005630782,0.000795569,0.0004499877,0.0001642629,0.0004657365,0.001317447,0.0004541948],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002168574,"about_ca_system_score_gemma":0.001753925,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006691019,"about_ca_topic_score_gemma":0.00001741579,"domain_scores_codex":[0.9949287,0.0005112467,0.0006325822,0.001045716,0.001385144,0.001496667],"domain_scores_gemma":[0.9967367,0.00132081,0.0001379282,0.0009122363,0.0008333671,0.00005892825],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002847627,0.0001376589,0.00008379235,0.02169618,0.0003822478,0.0001075326,0.00003687144,2.290226e-11,0.01070053,0.0004854723,0.001564255,0.9645207],"study_design_scores_gemma":[0.001138792,0.0009771315,0.000007753661,0.01012515,0.0001864872,0.00003510161,0.00002131533,0.000005573806,0.01829311,0.0006091787,0.9682347,0.0003656942],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0007642561,0.9875301,0.00007091657,0.0005357552,0.0001064809,0.006522755,0.00009236895,0.00006974185,0.004307687],"genre_scores_gemma":[0.0005465329,0.9922318,0.0001818384,0.001724049,0.001022052,0.001482827,0.00002099535,0.0001999075,0.00258993],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9666705,"threshold_uncertainty_score":0.9999007,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2014016939","doi":"10.1016/j.antiviral.2011.06.003","title":"Minigenomes, transcription and replication competent virus-like particles and beyond: Reverse genetics systems for filoviruses and other negative stranded hemorrhagic fever viruses","year":2011,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Viral Infections and Outbreaks Research","field":"Medicine","cited_by":134,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Canadian Institutes of Health Research; National Institutes of Health","keywords":"Biology; Virology; Reverse genetics; Viral replication; Virus; Transcription (linguistics); Viral life cycle; Marburg virus; Reverse transcriptase; Genome; Genetics; RNA; Computational biology; Ebola virus; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.3154312292024623,"gpt":0.4561723369112449,"spread":0.1407411077087826,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001629713,0.0003735958,0.001109376,0.00050129,0.0003929315,0.0002020738,0.0001194676,0.0003332142,0.00002178838],"category_scores_gemma":[0.0002160433,0.0002853445,0.0001674568,0.0004091969,0.0006732108,0.000169384,0.0001115856,0.0005959925,0.00002425609],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009635161,"about_ca_system_score_gemma":0.0002476303,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001137175,"about_ca_topic_score_gemma":0.0002053857,"domain_scores_codex":[0.9968987,0.0005762346,0.0005890562,0.0008852261,0.0004444841,0.000606373],"domain_scores_gemma":[0.998141,0.0006360401,0.0001439868,0.0005152887,0.0003501653,0.0002135046],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005353532,0.0003590603,0.000706876,0.02178835,0.0005556955,0.00002667753,0.0008913432,7.104821e-8,0.006515982,0.0009120048,0.00255367,0.9651549],"study_design_scores_gemma":[0.001513611,0.001315244,0.0004241345,0.00271996,0.0006315965,0.0001333336,0.000528626,0.0002586324,0.001154008,0.0002752673,0.9906234,0.0004221691],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.02566347,0.9689815,0.00007299529,0.00006558365,0.00008299592,0.004193433,0.0004526179,0.00004018228,0.0004472215],"genre_scores_gemma":[0.01681028,0.980814,0.0003819226,0.0001013794,0.0001530655,0.0004913942,0.00004632602,0.00008249714,0.001119076],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9880698,"threshold_uncertainty_score":0.9999599,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1974685109","doi":"10.1016/j.antiviral.2012.06.003","title":"Countermeasures against viral diseases of farmed fish","year":2012,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Aquaculture disease management and microbiota","field":"Immunology and Microbiology","cited_by":132,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University Medical Centre; University of Prince Edward Island","funders":"","keywords":"Aquaculture; Biology; Fish farming; Outbreak; Fish <Actinopterygii>; Population; Biotechnology; Fishery; Virology; Environmental health; Medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.1246550332103546,"gpt":0.4021714001815911,"spread":0.2775163669712365,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009370724,0.0005184477,0.001657708,0.0005793056,0.0002759997,0.00005208297,0.001054048,0.0006264799,0.0002618592],"category_scores_gemma":[0.0002163516,0.0003846865,0.0008369379,0.0005235435,0.001033364,0.000174079,0.0007145698,0.00108505,0.002334413],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001059889,"about_ca_system_score_gemma":0.0003264137,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004193691,"about_ca_topic_score_gemma":0.00001537403,"domain_scores_codex":[0.9959437,0.001389624,0.0006798637,0.0005972137,0.0002222004,0.001167362],"domain_scores_gemma":[0.9982949,0.0003706346,0.0002960911,0.0007224911,0.0002685836,0.00004733102],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007280234,0.0004777223,0.00009143666,0.0107546,0.00109059,0.00002276888,0.00007642469,5.244695e-9,0.001267272,0.0005889363,0.09369447,0.891863],"study_design_scores_gemma":[0.0003761475,0.00007807967,0.00009716335,0.003280622,0.0008460828,0.000004000402,0.00007393194,3.614773e-8,0.0002907183,0.00001656475,0.9945585,0.0003782146],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002650011,0.9895793,0.000001660977,0.00002042365,0.0005167098,0.001138339,0.001241662,0.00006123041,0.00717574],"genre_scores_gemma":[0.01566495,0.9673018,0.000002635479,0.00003940047,0.0001657076,0.0001068376,0.003379849,0.00006968183,0.01326909],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9008639,"threshold_uncertainty_score":0.9998605,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2037465112","doi":"10.1016/j.antiviral.2013.01.003","title":"Current and future approaches to the therapy of human rabies","year":2013,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Rabies epidemiology and control","field":"Immunology and Microbiology","cited_by":131,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba","funders":"","keywords":"Rabies; Rabies virus; Medicine; Regimen; Coma (optics); Rabies vaccine; Intensive care medicine; Disease; Immunology; Virology; Surgery; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.4699903491001967,"gpt":0.4608586767891744,"spread":0.009131672311022299,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00273858,0.0003017818,0.001377598,0.0002532038,0.0004591453,0.00002340016,0.0007660699,0.0005654954,0.00008559035],"category_scores_gemma":[0.0001740749,0.0001514363,0.0002746965,0.0003007576,0.001040937,0.00005101075,0.0003350278,0.00174348,0.0006114729],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001842072,"about_ca_system_score_gemma":0.0001225579,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007000195,"about_ca_topic_score_gemma":0.00001488782,"domain_scores_codex":[0.9948372,0.003531516,0.0004905431,0.0004667704,0.00007809757,0.0005958694],"domain_scores_gemma":[0.997844,0.001283043,0.0001596437,0.0006023813,0.00009201154,0.00001896175],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000201215,0.00004937128,0.00003474187,0.0007134112,0.0002609211,4.864312e-7,0.000170629,3.867076e-9,0.0001223972,0.008010032,0.01646709,0.9741508],"study_design_scores_gemma":[0.0001971712,0.0002628034,0.0001496523,0.0006325206,0.00003743361,0.000007411119,0.0001368249,9.945309e-8,0.00007462801,0.0003630506,0.9979914,0.0001469325],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0008546899,0.9951509,0.000002799401,0.001098715,0.0003520796,0.001595239,0.00003101335,0.00001473584,0.000899883],"genre_scores_gemma":[0.002561735,0.9948041,0.000004918759,0.00002565191,0.0003331449,0.0004833232,0.00007775052,0.00002387415,0.00168549],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9815244,"threshold_uncertainty_score":0.7859451,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2013130286","doi":"10.1016/j.antiviral.2006.06.011","title":"Resveratrol suppresses nuclear factor-κB in herpes simplex virus infected cells","year":2006,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BioPhage Pharma (Canada)","funders":"","keywords":"Herpes simplex virus; Resveratrol; Vero cell; Viral replication; Virology; Biology; Virus; NF-κB; IκBα; Molecular biology; Cell biology; Signal transduction; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.05431705798884728,"gpt":0.3811911008338261,"spread":0.3268740428449788,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003414394,0.0001867259,0.0003111055,0.0005107531,0.0002259086,0.0001012696,0.0001148386,0.0001748012,0.0005448031],"category_scores_gemma":[0.000138323,0.000156608,0.0001019997,0.0008997994,0.0001909584,0.0002090456,0.0001063143,0.0004960321,0.001170401],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001867029,"about_ca_system_score_gemma":0.0001529597,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01323449,"about_ca_topic_score_gemma":0.001734138,"domain_scores_codex":[0.997681,0.000282469,0.0002972871,0.0003955049,0.0006046574,0.0007390375],"domain_scores_gemma":[0.9990254,0.0002765785,0.00003215094,0.0003877033,0.0001975134,0.00008067513],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00120618,0.006606117,0.1887159,0.0002308882,0.0002793282,0.002310332,0.0005036048,0.00001325976,0.5248527,0.001976135,0.04053039,0.2327752],"study_design_scores_gemma":[0.003320499,0.0006393339,0.2720906,0.0001166717,0.00002297757,0.00001066388,0.00008238441,0.0002189373,0.3597437,0.000521826,0.3629697,0.000262753],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9701062,0.00009945057,0.000004963681,0.0002201341,0.00006957326,0.0005116834,0.00004986173,0.00009251172,0.02884563],"genre_scores_gemma":[0.9969923,0.0001661047,0.00009372186,0.0000535153,0.0001674127,0.00002703225,0.0000343031,0.00004691799,0.002418691],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3224393,"threshold_uncertainty_score":0.9996073,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2462974575","doi":"10.1016/j.antiviral.2016.07.004","title":"Nucleic acid polymers: Broad spectrum antiviral activity, antiviral mechanisms and optimization for the treatment of hepatitis B and hepatitis D infection","year":2016,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BioPhage Pharma (Canada)","funders":"","keywords":"Nucleic acid; Virology; Broad spectrum; Antiviral treatment; Antiviral therapy; Hepatitis; Medicine; Biology; Chemistry; Chronic hepatitis; Virus; Combinatorial chemistry; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.08977392654334417,"gpt":0.4036727077382293,"spread":0.3138987811948851,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009501298,0.0006840672,0.002215352,0.0007652829,0.0006677513,0.0001376687,0.0001717033,0.0004440944,0.00004068336],"category_scores_gemma":[0.0004176036,0.0004248261,0.0005022712,0.0007106744,0.0009583977,0.0003840599,0.0002846675,0.0004331149,0.00002858137],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004184098,"about_ca_system_score_gemma":0.0003965779,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01037293,"about_ca_topic_score_gemma":0.002933945,"domain_scores_codex":[0.9959187,0.0006769639,0.0006757926,0.0009440981,0.0008407065,0.0009437369],"domain_scores_gemma":[0.9972134,0.001395526,0.0003794621,0.0006285678,0.0002811064,0.0001019804],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001472769,0.0003242903,0.005902995,0.004122547,0.0008015093,0.00003323111,0.0001772298,5.398281e-8,0.0003430153,0.0004208354,0.0001635989,0.9875634],"study_design_scores_gemma":[0.0158029,0.05552188,0.03849543,0.0686731,0.008729735,0.0004197558,0.0001385664,0.005845248,0.03784378,0.002480872,0.7612957,0.00475308],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01266634,0.9756476,0.003009748,0.000567177,0.0003863266,0.006011092,0.0006855573,0.00008912138,0.0009370517],"genre_scores_gemma":[0.120206,0.8774379,0.0004894723,0.00001207133,0.0003467105,0.000491801,0.00006669835,0.0001295225,0.0008198593],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9828103,"threshold_uncertainty_score":0.9998204,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2029796174","doi":"10.1016/j.antiviral.2003.07.001","title":"Effect of topically applied resveratrol on cutaneous herpes simplex virus infections in hairless mice","year":2003,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BioPhage Pharma (Canada)","funders":"","keywords":"Resveratrol; Hairless; Lesion; Herpes simplex virus; Erythema; In vivo; Pharmacology; Medicine; Virus; In vitro; Dermatology; Chemistry; Immunology; Biology; Surgery; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.03585109773665064,"gpt":0.4003792802078429,"spread":0.3645281824711922,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008193305,0.0001508187,0.0003466296,0.0004148861,0.000157946,0.00002222232,0.0000685531,0.0001406824,0.00008396697],"category_scores_gemma":[0.000551669,0.0001177902,0.00009609546,0.0007320699,0.0001618762,0.00004129332,0.00003052601,0.0004551244,0.0002363458],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001544522,"about_ca_system_score_gemma":0.0001394877,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009310744,"about_ca_topic_score_gemma":0.0003325247,"domain_scores_codex":[0.9980171,0.00051671,0.000254658,0.0003094268,0.0004554684,0.0004466885],"domain_scores_gemma":[0.9985428,0.000928222,0.00003142413,0.0003255838,0.00009989239,0.0000720492],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00301805,0.004743854,0.05883974,0.0003700411,0.0003212278,0.0008867261,0.000304129,0.00002973768,0.05991212,0.01354687,0.0007416023,0.8572859],"study_design_scores_gemma":[0.00731387,0.00884303,0.008217604,0.0002582687,0.00007537834,0.00010439,0.00007516405,0.0001121312,0.8900098,0.0006867053,0.08401762,0.0002860895],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9074891,0.00003345344,0.00002342034,0.00008548111,0.00005725506,0.0007110521,0.000006271069,0.00002863367,0.09156539],"genre_scores_gemma":[0.9987134,0.00008032218,0.00004690612,0.00004063258,0.00003758736,0.00009686523,0.000006372371,0.00002183179,0.0009560932],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8569998,"threshold_uncertainty_score":0.4803345,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1969487400","doi":"10.1016/j.antiviral.2006.07.004","title":"Resveratrol inhibition of varicella-zoster virus replication in vitro","year":2006,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BioPhage Pharma (Canada)","funders":"","keywords":"Resveratrol; Varicella zoster virus; Virus; Virology; Viral replication; Biology; In vitro; Western blot; Replication (statistics); Pharmacology; Gene; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.05591106995852922,"gpt":0.3926330302860512,"spread":0.336721960327522,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007427316,0.00006885698,0.0001534109,0.0003799465,0.00006336095,0.00001463638,0.00003189947,0.00008222749,0.00003153387],"category_scores_gemma":[0.00009373364,0.00005946526,0.00004988653,0.0006573974,0.00008683298,0.00009291759,0.00003372584,0.0002389429,0.0001630247],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001253915,"about_ca_system_score_gemma":0.00007804023,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004257718,"about_ca_topic_score_gemma":0.0001701775,"domain_scores_codex":[0.998745,0.000136283,0.0002415154,0.0002584918,0.0003662847,0.0002524127],"domain_scores_gemma":[0.9992832,0.00009121605,0.00003547604,0.000380823,0.0001865135,0.00002276462],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0004322997,0.0008173885,0.01584139,0.00003358481,0.00001436776,0.00006236835,0.00003556689,5.840195e-7,0.9492715,0.0005016169,0.0009286754,0.03206069],"study_design_scores_gemma":[0.001214778,0.0002156313,0.07078335,0.00005291573,0.000009864735,0.000005815165,0.00001692953,0.0001230116,0.9226963,0.0008428658,0.003989064,0.00004950861],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.952179,0.0000771582,0.00004860027,0.0003114839,0.00001977233,0.0003732245,0.00001057343,0.00001651649,0.04696373],"genre_scores_gemma":[0.997445,0.00004328588,0.0001873804,0.00003043784,0.00007061085,0.00004435606,0.0000619129,0.00001222734,0.002104746],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05494196,"threshold_uncertainty_score":0.6436424,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2783963160","doi":"10.1016/j.antiviral.2018.01.002","title":"The role of adjuvant immunomodulatory agents for treatment of severe influenza","year":2018,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Immunology; Internal medicine; Pharmacology","retraction":null,"screen_n_in":null,"score":{"opus":0.3956414398444933,"gpt":0.5558238068627308,"spread":0.1601823670182375,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002353648,0.0004085971,0.002297745,0.000505701,0.0004243209,0.00002852308,0.0005835433,0.000295341,0.00001604009],"category_scores_gemma":[0.001693921,0.0002216828,0.001016294,0.0006533813,0.001522752,0.00006936165,0.0004187643,0.0003620608,0.0001387308],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004896265,"about_ca_system_score_gemma":0.001748738,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002440986,"about_ca_topic_score_gemma":0.00001924875,"domain_scores_codex":[0.995351,0.0006139746,0.001036028,0.0005016983,0.001479446,0.001017894],"domain_scores_gemma":[0.9943344,0.002293658,0.0003525904,0.001246525,0.001683771,0.00008903995],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00060003,0.0003369894,0.0002166474,0.01002349,0.001680574,0.000008971222,0.0002504633,2.215988e-8,0.000105978,0.0003191232,0.001859379,0.9845983],"study_design_scores_gemma":[0.001074389,0.003338484,0.0002249885,0.006285261,0.000354338,0.00000580776,0.0001840427,0.000006854409,0.0009918093,0.000189167,0.9871858,0.0001590256],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001591091,0.9893504,4.158082e-7,0.00001510016,0.00007688446,0.00438683,0.0003023402,0.00001336986,0.004263537],"genre_scores_gemma":[0.001229038,0.9942129,0.00006404986,0.000006771573,0.000268146,0.0007259548,0.00004180059,0.00008148536,0.003369897],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9853265,"threshold_uncertainty_score":0.9039962,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1965398894","doi":"10.1016/j.antiviral.2011.10.019","title":"Do viral infections mimic bacterial sepsis? The role of microvascular permeability: A review of mechanisms and methods","year":2011,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Viral Infections and Vectors","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Dengue virus; Sepsis; Immunology; Context (archaeology); Dengue fever; Biology; Immunosuppression; Pathogenesis; Immune system; Viral pathogenesis; Virus; Virology; Medicine; Viral replication","retraction":null,"screen_n_in":null,"score":{"opus":0.1318230734043114,"gpt":0.4872482166468658,"spread":0.3554251432425544,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006580052,0.0003460341,0.002225704,0.0005090937,0.0001896629,0.00002839164,0.0002781294,0.0003406376,0.000268342],"category_scores_gemma":[0.001116168,0.0002055794,0.001125293,0.001108476,0.0006902696,0.00009953567,0.000313213,0.001141099,0.00002767066],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008002332,"about_ca_system_score_gemma":0.0005386836,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005800474,"about_ca_topic_score_gemma":0.00001192836,"domain_scores_codex":[0.9947708,0.002895392,0.0009205806,0.0005209162,0.0004532612,0.0004390509],"domain_scores_gemma":[0.9973741,0.0006406534,0.0003006631,0.00104521,0.0005573272,0.00008209526],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002451889,0.0002750234,0.00002783515,0.0667768,0.0005287487,0.000002251032,0.00006822617,1.576278e-9,0.003475534,0.002356931,0.0001452133,0.9263189],"study_design_scores_gemma":[0.0002383074,0.001336296,0.00003777672,0.05556845,0.001815572,0.0001034972,0.00004823627,0.000002655249,0.002248033,0.001341193,0.9370519,0.000208124],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0008082126,0.994738,0.00009804835,0.00003565491,0.0001508128,0.002235969,0.00004157773,0.00001845604,0.001873259],"genre_scores_gemma":[0.0009522694,0.9973954,0.001077762,0.00001646542,0.0001243299,0.0001894948,0.00004152508,0.00005393495,0.0001488404],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9369066,"threshold_uncertainty_score":0.8383285,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2081116136","doi":"10.1016/j.antiviral.2013.09.018","title":"Universal anti-neuraminidase antibody inhibiting all influenza A subtypes","year":2013,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Public Health Agency of Canada; University of Ottawa; Health Canada","funders":"","keywords":"Epitope; Neuraminidase; Monoclonal antibody; Virology; Antibody; Biology; Influenza A virus; Virus; Viral replication; Amino acid; Peptide sequence; Immunology; Biochemistry; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.183977696330882,"gpt":0.4747452553409837,"spread":0.2907675590101018,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001742293,0.0002856099,0.0005065306,0.0008402016,0.0004789687,0.0002210572,0.0003478413,0.0001813277,0.0002457783],"category_scores_gemma":[0.002794618,0.0002361547,0.0001566052,0.001190779,0.0009757814,0.0007211487,0.0007588053,0.001464745,0.00483252],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001899597,"about_ca_system_score_gemma":0.0003784617,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001997616,"about_ca_topic_score_gemma":0.0000199467,"domain_scores_codex":[0.9949313,0.0004473167,0.0004205872,0.0006479841,0.001856333,0.001696503],"domain_scores_gemma":[0.9968745,0.0007563398,0.00006663405,0.000579042,0.001454039,0.0002694187],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.0002748545,0.0003271754,0.1707204,0.0002618378,0.0002382512,0.0007166794,0.0008350925,8.322878e-7,0.8024454,0.001000187,0.0133634,0.009815899],"study_design_scores_gemma":[0.006119503,0.002324061,0.6174193,0.0007892069,0.00008238709,0.00006892685,0.004703662,0.001634737,0.3145988,0.0007428619,0.05060538,0.0009111746],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.960901,0.0005301107,0.000008526868,0.001852807,0.00005306969,0.001200941,0.00001274013,0.0001465862,0.03529424],"genre_scores_gemma":[0.9953581,0.0003741875,0.0002691366,0.0008662103,0.0002576741,0.00005443779,0.0000258203,0.00005999035,0.002734419],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4878466,"threshold_uncertainty_score":0.9959424,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2000176602","doi":"10.1016/j.antiviral.2005.07.003","title":"Selection and characterization of HIV-1 showing reduced susceptibility to the non-peptidic protease inhibitor tipranavir","year":2005,"lang":"en","type":"article","venue":"Antiviral Research","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":106,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Protease; Biology; Virology; HIV-1 protease; Protease inhibitor (pharmacology); Saquinavir; Mutation; Genetics; Virus; Enzyme; Gene; Biochemistry; Viral load; Antiretroviral therapy","retraction":null,"screen_n_in":null,"score":{"opus":0.03610441450119085,"gpt":0.3331935398410232,"spread":0.2970891253398323,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001357322,0.000101777,0.0001532824,0.0001813015,0.0003760431,0.00003029221,0.0001481543,0.00009832441,0.00008498529],"category_scores_gemma":[0.0002540749,0.00006994911,0.00004097877,0.0004218851,0.0002133565,0.0001675899,0.0001411383,0.0004024888,0.001089887],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007767921,"about_ca_system_score_gemma":0.0001330684,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001829787,"about_ca_topic_score_gemma":0.0001694066,"domain_scores_codex":[0.9983214,0.0005645663,0.0001968919,0.0003112874,0.0001429209,0.0004629268],"domain_scores_gemma":[0.9993612,0.0001305173,0.00003316006,0.0002312271,0.0002088677,0.0000349898],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00033665,0.0001696375,0.01011149,0.00001974702,0.00003729996,0.000001487549,0.0005381548,2.471875e-7,0.9474652,0.0000257883,0.0009523353,0.04034196],"study_design_scores_gemma":[0.0006304235,0.000576979,0.1054848,0.00004046081,0.000006276952,0.000005265774,0.0001175296,0.00003820641,0.8871034,0.00000830626,0.005916886,0.0000713582],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9957431,0.00005955375,0.00006410736,0.002531934,0.00003823393,0.001103322,0.00006272984,0.00001715941,0.0003798559],"genre_scores_gemma":[0.9967998,0.00004824184,0.00005033079,0.0000216162,0.00008772112,0.0001064375,0.000135209,0.00001065224,0.002739967],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09537335,"threshold_uncertainty_score":0.9996879,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2072181122","doi":"10.1016/j.antiviral.2005.06.008","title":"Effect of resveratrol on herpes simplex virus vaginal infection in the mouse","year":2005,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BioPhage Pharma (Canada)","funders":"","keywords":"Resveratrol; Herpes simplex virus; Placebo; Virus; Vagina; Viral shedding; Viral replication; Medicine; Biology; Immunology; Virology; Pharmacology; Internal medicine; Surgery; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.05557920624458813,"gpt":0.4385959232346391,"spread":0.383016716990051,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002017647,0.0001097121,0.000198218,0.0003414547,0.0001351885,0.00002579205,0.00007511394,0.0000791531,0.000051424],"category_scores_gemma":[0.0002802793,0.00006488417,0.00008386133,0.0005840969,0.0001243598,0.0001015911,0.00002802077,0.0004251249,0.0003239259],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001212807,"about_ca_system_score_gemma":0.00005867135,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002527148,"about_ca_topic_score_gemma":0.0007203577,"domain_scores_codex":[0.9979561,0.0007693329,0.0001767401,0.0001970587,0.0005681815,0.0003325848],"domain_scores_gemma":[0.9989827,0.0005711245,0.000025638,0.0003116549,0.00007761695,0.0000313118],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001604969,0.001511718,0.07004747,0.00008133375,0.00008420657,0.0000829913,0.0002879453,0.0000122062,0.008703359,0.0005115726,0.002761438,0.9143108],"study_design_scores_gemma":[0.005180772,0.009192925,0.1317018,0.0001281619,0.00005088891,0.00002016005,0.00003222933,0.0004102209,0.7185636,0.00008626655,0.1344945,0.0001384958],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9836626,0.00004279657,0.000005744806,0.0005136417,0.00002059542,0.0005793664,0.000005969531,0.00001902955,0.01515024],"genre_scores_gemma":[0.9987493,0.0001758239,0.00001420231,0.00008491991,0.0001434979,0.00006706254,0.000009101643,0.00001360677,0.0007424714],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9141723,"threshold_uncertainty_score":0.416352,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2031242404","doi":"10.1016/j.antiviral.2007.03.010","title":"Chemical properties, mode of action, and in vivo anti-herpes activities of a lignin–carbohydrate complex from Prunella vulgaris","year":2007,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Natural product bioactivities and synthesis","field":"Biochemistry, Genetics and Molecular Biology","cited_by":105,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University","funders":"Innovation and Technology Fund; Chinese University of Hong Kong; University of Hong Kong; Dalhousie University","keywords":"Prunella vulgaris; In vivo; Rhamnose; Vero cell; Biochemistry; Galactose; Polysaccharide; Microbiology; Chemistry; Biology; In vitro; Pharmacology; Medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.06156448742838446,"gpt":0.3458857927590903,"spread":0.2843213053307059,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006010895,0.0001321113,0.000278525,0.0001444365,0.00005122241,0.00001699274,0.0001734178,0.0001774514,0.000006222336],"category_scores_gemma":[0.0001651377,0.0001115167,0.00005681812,0.0001905577,0.0005305035,0.00001642209,0.0002017817,0.000183842,6.531449e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001761731,"about_ca_system_score_gemma":0.00008054751,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002118668,"about_ca_topic_score_gemma":0.0003742827,"domain_scores_codex":[0.9985678,0.0001411533,0.000273742,0.0003522431,0.0003115833,0.0003534784],"domain_scores_gemma":[0.9993961,0.0001028187,0.00007554289,0.0002614444,0.0001278705,0.00003625557],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0005158552,0.0001359183,0.003920638,0.00006445571,0.00004796876,0.000002806101,0.000173813,6.898303e-7,0.9888136,0.00002022974,0.000401479,0.005902544],"study_design_scores_gemma":[0.0002690369,0.000107356,0.003765455,0.00004527192,0.000005666596,0.000001067237,0.0006851,0.00008640614,0.9942486,0.00009317416,0.0005709911,0.0001218221],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.998113,0.0006464266,0.00001313095,0.0001121922,0.00002937244,0.0001906452,0.00004530133,0.000004468082,0.0008454641],"genre_scores_gemma":[0.9987735,0.0005876254,0.0002194807,0.00001140226,0.0001057252,0.00000507667,0.00001481343,0.00001689744,0.0002655192],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005780722,"threshold_uncertainty_score":0.4547518,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2912481674","doi":"10.1016/j.antiviral.2019.01.011","title":"Clinical development of letermovir and maribavir: Overview of human cytomegalovirus drug resistance","year":2019,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval","funders":"Canadian Institutes of Health Research; Merck Sharp and Dohme; Canada Research Chairs","keywords":"Human cytomegalovirus; Virology; Biology; Drug resistance; Ganciclovir; Virus; Microbiology","retraction":null,"screen_n_in":null,"score":{"opus":0.4270970719036665,"gpt":0.5536105815723571,"spread":0.1265135096686906,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.009320132,0.0005710174,0.00488486,0.001382363,0.000234303,0.00006290949,0.0008085608,0.0006581629,0.0001277286],"category_scores_gemma":[0.0006454444,0.000447972,0.0009198678,0.001441265,0.001348391,0.0001472622,0.001292367,0.002672869,0.0003388192],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002547625,"about_ca_system_score_gemma":0.003359281,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001529297,"about_ca_topic_score_gemma":0.0002279607,"domain_scores_codex":[0.9911377,0.001475943,0.002798863,0.001151478,0.002384972,0.001051014],"domain_scores_gemma":[0.9950921,0.00176454,0.0006567194,0.001461225,0.0007578693,0.0002675799],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002486485,0.0004374431,0.0008272504,0.1035217,0.0005274991,0.00008868978,0.0001386025,7.667823e-10,0.0002501787,0.0007438473,0.003410025,0.8898061],"study_design_scores_gemma":[0.001015876,0.0003247009,0.001349218,0.03221062,0.0002861426,0.000009929649,0.00002880176,9.050024e-7,0.0003250813,0.00005730785,0.9640288,0.0003626463],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.009158513,0.975901,0.000001848877,0.00004186287,0.00008481224,0.002344188,0.00009723916,0.00002217471,0.01234834],"genre_scores_gemma":[0.005686621,0.9723867,0.0005866237,0.00001616159,0.0001655421,0.00008225578,0.000114642,0.0001276685,0.02083385],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9606187,"threshold_uncertainty_score":0.9997972,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2556090342","doi":"10.1016/j.antiviral.2016.11.017","title":"Synergistic drug combination effectively blocks Ebola virus infection","year":2016,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Viral Infections and Outbreaks Research","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba; Public Health Agency of Canada","funders":"National Institute of Allergy and Infectious Diseases; National Center for GM Crops; National Institutes of Health","keywords":"Ebola virus; Drug; Posaconazole; Ebolavirus; Virology; Pharmacology; Toremifene; Mefloquine; Medicine; Antiviral drug; Biology; Virus; Immunology; Microbiology; Malaria; Internal medicine; Chloroquine; Amphotericin B","retraction":null,"screen_n_in":null,"score":{"opus":0.05798860668639612,"gpt":0.4058258055016807,"spread":0.3478371988152846,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002276658,0.0001738817,0.0002779825,0.0008200814,0.0004627935,0.0000864198,0.0001124028,0.0001439556,0.0002207677],"category_scores_gemma":[0.001695704,0.0001128601,0.0001457881,0.001070853,0.0004320463,0.0003114547,0.000177438,0.0006379073,0.001564255],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003889245,"about_ca_system_score_gemma":0.0002184451,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002754021,"about_ca_topic_score_gemma":0.0002694952,"domain_scores_codex":[0.9968365,0.0005782811,0.0002558636,0.0004714843,0.001108666,0.0007491345],"domain_scores_gemma":[0.9976007,0.0009818028,0.00004206705,0.0003556279,0.0008660145,0.0001537324],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003476187,0.0005269268,0.0326313,0.00007211466,0.00006531692,0.00007725332,0.00005664486,1.83525e-7,0.8583345,0.001904189,0.007985985,0.09799796],"study_design_scores_gemma":[0.002983505,0.001632986,0.2063861,0.0003807746,0.0000323815,0.00003112834,0.00003323896,0.0003241312,0.7787402,0.002626511,0.006590085,0.0002389901],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9649062,0.00006171572,0.001247759,0.001491173,0.0001885673,0.0007493546,0.00001123562,0.0001322381,0.03121179],"genre_scores_gemma":[0.9767158,0.0004707766,0.00002571884,0.00003866805,0.0002744544,0.0001168302,0.000008387503,0.00003677205,0.02231259],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1737548,"threshold_uncertainty_score":0.9992132,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3154943564","doi":"10.1016/j.antiviral.2021.105078","title":"A cell-based assay to discover inhibitors of SARS-CoV-2 RNA dependent RNA polymerase","year":2021,"lang":"en","type":"article","venue":"Antiviral Research","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Exoribonuclease; RNA-dependent RNA polymerase; Virology; Biology; Proofreading; Polymerase; RNA polymerase; Favipiravir; RNA; Genetics; Gene; Coronavirus disease 2019 (COVID-19); Medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.08491855043424056,"gpt":0.4161720030832382,"spread":0.3312534526489976,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002507922,0.0002894281,0.0005888317,0.000866253,0.0001915601,0.0001317947,0.0004477413,0.0002186558,0.0000285767],"category_scores_gemma":[0.001750141,0.0002530085,0.0003113714,0.002181399,0.0003407275,0.0001927855,0.0005647886,0.001110493,0.0006421335],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002748563,"about_ca_system_score_gemma":0.002818685,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002112417,"about_ca_topic_score_gemma":0.0003072239,"domain_scores_codex":[0.9934753,0.0007381334,0.0005461348,0.000844406,0.003129611,0.001266454],"domain_scores_gemma":[0.9970357,0.0007790477,0.00006913425,0.001063506,0.0009495275,0.0001030879],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0009616392,0.0009583626,0.01558939,0.000298282,0.00006392082,0.001619754,0.0002583462,3.09575e-7,0.9659555,0.00009994644,0.007606478,0.006588093],"study_design_scores_gemma":[0.002207676,0.0007573446,0.001536219,0.0002742141,0.00002663549,0.00001063081,0.0003888192,0.0002030701,0.9852272,0.00006769926,0.009060077,0.0002404177],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9716256,0.0007781448,0.0003518709,0.001940228,0.0001644996,0.0007045692,0.0000437838,0.00004345429,0.02434788],"genre_scores_gemma":[0.9890555,0.00001352092,0.0001918559,0.009346955,0.0002786175,0.00007003421,0.00001387738,0.00007259394,0.0009570634],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02339082,"threshold_uncertainty_score":0.9999922,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3095531782","doi":"10.1016/j.antiviral.2020.104970","title":"Burden of influenza B virus infection and considerations for clinical management","year":2020,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"Department of Health and Aged Care, Australian Government; Roche","keywords":"Medicine; Epidemiology; Pandemic; Neuraminidase; Disease; Intensive care medicine; Disease burden; Virology; Virus; Clinical trial; Neuraminidase inhibitor; Disease management; Immunology; Infectious disease (medical specialty); Coronavirus disease 2019 (COVID-19); Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.6702519866143979,"gpt":0.6349529966941866,"spread":0.0352989899202113,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003183337,0.000284521,0.001943397,0.0006644849,0.0002815162,0.00006398973,0.0001208069,0.0003108024,0.00002071023],"category_scores_gemma":[0.006496262,0.00022314,0.0004915511,0.0006243872,0.000821957,0.0000933775,0.0006407422,0.001218502,0.0001256628],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001187165,"about_ca_system_score_gemma":0.0006331466,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002151398,"about_ca_topic_score_gemma":0.00002104226,"domain_scores_codex":[0.9961102,0.0007488302,0.001078523,0.000624039,0.0008879253,0.0005504556],"domain_scores_gemma":[0.9948482,0.003634118,0.0001854653,0.0004383055,0.0007527514,0.000141183],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001626027,0.0001113068,0.0001767348,0.03831701,0.001243684,0.00008565888,0.00009552381,4.053426e-8,0.000009059949,0.001943578,0.01307354,0.9447812],"study_design_scores_gemma":[0.0009568182,0.0009366477,0.0001645102,0.005517743,0.0005762635,0.00001113112,0.00003723921,0.00001843647,0.00002122981,0.0004632307,0.9911382,0.0001586032],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001976348,0.9900428,0.0000228851,0.0002252226,0.00007681533,0.004717926,0.0001301005,0.00003547576,0.004551117],"genre_scores_gemma":[0.0002008888,0.9973574,0.0007304223,0.00008057107,0.0004449739,0.0005654414,0.00002522996,0.00005418939,0.0005408494],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9780646,"threshold_uncertainty_score":0.9099386,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1980089445","doi":"10.1016/j.antiviral.2007.03.013","title":"Interactions of macrophages with probiotic bacteria lead to increased antiviral response against vesicular stomatitis virus","year":2007,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Probiotics and Fermented Foods","field":"Agricultural and Biological Sciences","cited_by":91,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Food Inspection Agency","funders":"","keywords":"Vesicular stomatitis virus; Biology; Immune system; Proinflammatory cytokine; Microbiology; Virus; Lactobacillus rhamnosus; Innate immune system; Probiotic; Interferon; Chemokine; Cytokine; Lipopolysaccharide; Vesicular stomatitis Indiana virus; Immunology; Virology; Inflammation; Bacteria","retraction":null,"screen_n_in":null,"score":{"opus":0.03826843277098236,"gpt":0.325582049487448,"spread":0.2873136167164657,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002081583,0.0001660307,0.0002383771,0.0001262909,0.0002789882,0.0001012523,0.0003581486,0.00008503329,0.00004753686],"category_scores_gemma":[0.000235101,0.00007103162,0.00007694171,0.001166401,0.0002431504,0.000196703,0.0001946543,0.0003279942,0.0001147484],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006541147,"about_ca_system_score_gemma":0.00003988652,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005390177,"about_ca_topic_score_gemma":0.001271128,"domain_scores_codex":[0.9977766,0.00040479,0.0002938876,0.0003698849,0.0005056116,0.0006492196],"domain_scores_gemma":[0.9988618,0.0005413392,0.0000730672,0.000139437,0.000279144,0.0001052443],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001583471,0.0002535675,0.002523781,0.00001373593,0.00002805615,0.00008204535,0.00009847317,2.500264e-7,0.9679592,0.00007123523,0.000270742,0.02711539],"study_design_scores_gemma":[0.0002017529,0.001604647,0.319054,0.0001252802,0.000005625833,0.000004914555,0.0002900354,0.00002315774,0.6765762,0.00002415863,0.001934998,0.0001552667],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9967531,0.00002881254,0.000027762,0.0005880443,0.00005636936,0.000508424,0.0001025383,0.00004068083,0.001894276],"genre_scores_gemma":[0.9988272,0.00002432085,0.000417168,0.00008952269,0.0000833499,0.000009495225,0.00004268808,0.000003608425,0.0005026424],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3165302,"threshold_uncertainty_score":0.2896585,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1987049523","doi":"10.1016/s0166-3542(02)00054-2","title":"Evidence of dual sites of action of dendrimers: SPL-2999 inhibits both virus entry and late stages of herpes simplex virus replication","year":2002,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; St. Paul's Hospital","funders":"","keywords":"Vero cell; Herpes simplex virus; Virus; Multiplicity of infection; Virology; Dendrimer; Chemistry; Biology; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.2425639375113881,"gpt":0.4464273444798091,"spread":0.203863406968421,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007594922,0.0001054253,0.0003433523,0.0003145902,0.0000579762,0.000007158355,0.00005864619,0.0001081534,0.0001072701],"category_scores_gemma":[0.0006133222,0.00009003324,0.00007367838,0.0005229841,0.0003825551,0.0002343239,0.00007831919,0.0001710539,0.00001133409],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000385258,"about_ca_system_score_gemma":0.00006454371,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002169716,"about_ca_topic_score_gemma":0.0001754268,"domain_scores_codex":[0.9983004,0.0001863713,0.0004351251,0.000271228,0.0005890573,0.0002177986],"domain_scores_gemma":[0.9985212,0.0003777206,0.0002132564,0.0004207541,0.000417911,0.00004912737],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.000309276,0.0007215586,0.05746847,0.0004493192,0.0001304213,0.000006670043,0.0003483926,0.000001275407,0.7853601,0.00009034728,0.0001638689,0.1549503],"study_design_scores_gemma":[0.0006947797,0.0009513291,0.06585532,0.0005211249,0.00005611779,0.000004085935,0.00012036,0.0002078688,0.9310086,0.00005897058,0.000467555,0.0000539018],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9965196,0.001888539,0.00001231599,0.00007291311,0.00001558846,0.0003553316,0.0000423979,0.00001036343,0.001083003],"genre_scores_gemma":[0.9912267,0.007940243,0.0001806821,0.000005705155,0.00002510217,0.000009618803,0.000007830477,0.00001214123,0.0005920328],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1548964,"threshold_uncertainty_score":0.3671449,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2002008129","doi":"10.1016/j.antiviral.2015.04.003","title":"Limonium sinense and gallic acid suppress hepatitis C virus infection by blocking early viral entry","year":2015,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis C virus research","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Izaak Walton Killam Health Centre","funders":"U.S. Food and Drug Administration; Council of Agriculture","keywords":"Viral entry; Virology; Infectivity; Hepatitis C virus; Viral replication; Gallic acid; Biology; Viral hepatitis; Potency; Virus; In vitro; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.09149164725371801,"gpt":0.3952309950796019,"spread":0.3037393478258839,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002099638,0.0002561267,0.0004206414,0.0005683852,0.0002973858,0.0002964757,0.0001986095,0.0002799588,0.00006624801],"category_scores_gemma":[0.001714516,0.0002420465,0.00008651926,0.0007864147,0.000566364,0.0005519982,0.0004581282,0.001384309,0.0006075009],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002965611,"about_ca_system_score_gemma":0.0003912654,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.03426951,"about_ca_topic_score_gemma":0.001520626,"domain_scores_codex":[0.9949539,0.0007233914,0.0003655462,0.0006474295,0.002096449,0.001213242],"domain_scores_gemma":[0.997839,0.000253769,0.00005118559,0.000526323,0.0008096495,0.0005200716],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0005669602,0.000289243,0.6857817,0.0001035395,0.0000728899,0.0004087343,0.000547583,2.090227e-7,0.2521991,0.00008040882,0.03338312,0.02656654],"study_design_scores_gemma":[0.004975152,0.004755126,0.3038355,0.0003889399,0.00005581608,0.00008719371,0.0001082615,0.00235164,0.6230778,0.0004552197,0.05925847,0.0006509563],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9836993,0.0009886906,0.00006929946,0.0009429753,0.0001406861,0.0007374214,0.00005534894,0.0001135015,0.01325282],"genre_scores_gemma":[0.9906843,0.004726596,0.000125587,0.0001093359,0.0003433456,0.00007788213,0.00006415688,0.00007186717,0.003796977],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3819462,"threshold_uncertainty_score":0.9870371,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2050801792","doi":"10.1016/j.antiviral.2005.08.004","title":"Evaluation of dendrimer SPL7013, a lead microbicide candidate against herpes simplex viruses","year":2005,"lang":"en","type":"article","venue":"Antiviral Research","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":86,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"National Institutes of Health","keywords":"Vero cell; Herpes simplex virus; Dendrimer; Microbicide; HSL and HSV; Chemistry; Cytotoxicity; IC50; Virology; Cytotoxic T cell; In vitro; Virus; Biology; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.1340076992343101,"gpt":0.4291419716975172,"spread":0.2951342724632071,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003781874,0.000166959,0.0002738759,0.0003779584,0.0002852171,0.00002973846,0.0003274833,0.0001657252,0.000623884],"category_scores_gemma":[0.0005598774,0.0001360047,0.0001079696,0.0003893951,0.0005972924,0.0001931718,0.0001863636,0.0003752813,0.007262442],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002036708,"about_ca_system_score_gemma":0.000580708,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001474292,"about_ca_topic_score_gemma":0.001887574,"domain_scores_codex":[0.9963307,0.001625536,0.000315835,0.0003799807,0.0004822667,0.0008656605],"domain_scores_gemma":[0.9982718,0.0003415844,0.0000646378,0.0004124097,0.0008775373,0.00003208959],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001662286,0.0003265477,0.001481611,0.00001032622,0.0002521883,0.000007578892,0.0002129407,0.000003487703,0.6338268,0.00007330651,0.01157416,0.3520648],"study_design_scores_gemma":[0.002304684,0.0002588707,0.005177914,0.00004358837,0.00004732146,0.000005417984,0.0001928638,0.00005170993,0.8845749,0.00009142241,0.107121,0.0001303267],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9819099,0.005477924,0.000009090943,0.0004054046,0.000060365,0.0005878067,0.0001372928,0.00002750833,0.01138473],"genre_scores_gemma":[0.9963086,0.0004043536,0.00008124096,0.00005983648,0.0000512594,0.00006721464,0.0001917258,0.00002122907,0.002814532],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3519345,"threshold_uncertainty_score":0.9935105,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1671096404","doi":"10.1016/j.antiviral.2015.09.003","title":"Harmine blocks herpes simplex virus infection through downregulating cellular NF-κB and MAPK pathways induced by oxidative stress","year":2015,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Synthesis and bioactivity of alkaloids","field":"Biochemistry, Genetics and Molecular Biology","cited_by":84,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Ministry of Health, British Columbia","keywords":"Herpes simplex virus; MAPK/ERK pathway; Oxidative stress; Harmine; NF-κB; Virology; Virus; Biology; Chemistry; Immunology; Cell biology; Inflammation; Signal transduction; Pharmacology; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.1081964772295067,"gpt":0.3545332056548899,"spread":0.2463367284253832,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009263162,0.000202176,0.0002093872,0.00007133133,0.0002476999,0.0001205952,0.0001626124,0.0002527674,0.00001039645],"category_scores_gemma":[0.0004007551,0.0001791957,0.00006301863,0.000203944,0.0002541888,0.00003469015,0.0003351748,0.0002361181,0.0000150038],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003143201,"about_ca_system_score_gemma":0.0001036359,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002217352,"about_ca_topic_score_gemma":0.000325911,"domain_scores_codex":[0.9979666,0.0003334621,0.000192581,0.0005349113,0.0004713031,0.0005011136],"domain_scores_gemma":[0.9991915,0.00008084575,0.00007243989,0.0002982215,0.0002551396,0.0001018634],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001037943,0.0001684914,0.001420119,0.00001558609,0.00005154761,0.000004926807,0.0002047596,4.774108e-7,0.944482,0.00002953316,0.002922177,0.05059654],"study_design_scores_gemma":[0.0005034184,0.0006411822,0.0009758776,0.00002746298,0.000008418582,0.000002358973,0.0004741725,0.00007170151,0.982375,0.0002517588,0.01444527,0.0002234084],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.996417,0.0004655604,0.0002598219,0.0002129089,0.00005559226,0.0002501159,0.00007009078,0.0000192756,0.002249602],"genre_scores_gemma":[0.9985211,0.0003087051,0.0001949906,0.00004664709,0.0002792868,0.00002059299,0.0001426225,0.00002696379,0.0004590509],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05037313,"threshold_uncertainty_score":0.7307388,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2074806701","doi":"10.1016/j.antiviral.2008.01.152","title":"Treatment of Marburg and Ebola hemorrhagic fevers: A strategy for testing new drugs and vaccines under outbreak conditions","year":2008,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Viral Infections and Outbreaks Research","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Public Health Agency of Canada","keywords":"Outbreak; Case fatality rate; Medicine; Ebola virus; Ebolavirus; Marburg virus; Ebola vaccine; Infectious disease (medical specialty); Ebola Hemorrhagic Fever; Virology; Intensive care medicine; Disease; Clinical trial; Environmental health; Pathology; Population","retraction":null,"screen_n_in":null,"score":{"opus":0.3371074663774374,"gpt":0.5050210633326645,"spread":0.1679135969552271,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003607118,0.0003989036,0.001563287,0.0008614489,0.0003954142,0.00009064383,0.0001026631,0.0003129368,0.00002884979],"category_scores_gemma":[0.0003831735,0.0002841304,0.0003128113,0.0009109437,0.0003860439,0.0001348843,0.0001385893,0.0004870537,0.00002076207],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000198098,"about_ca_system_score_gemma":0.001603735,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001830093,"about_ca_topic_score_gemma":0.00004482894,"domain_scores_codex":[0.9973876,0.0002394144,0.0005474649,0.0006279669,0.000497299,0.0007002025],"domain_scores_gemma":[0.9966546,0.002113454,0.0001290244,0.0003495177,0.0005006213,0.0002528254],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006878104,0.0002649965,0.0001968756,0.005540563,0.0003027473,0.00007579564,0.00007718251,1.437437e-7,0.0001290869,0.0002287942,0.001631451,0.9914836],"study_design_scores_gemma":[0.01018412,0.01620445,0.002663285,0.01537437,0.001906172,0.003706982,0.001329986,0.0005950631,0.0004323246,0.002309289,0.944005,0.001288941],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00560221,0.9871106,0.00002540531,0.0002327962,0.00004302827,0.002994284,0.0001882514,0.00003843792,0.003765034],"genre_scores_gemma":[0.01440007,0.9716656,0.000371944,0.000008583602,0.0003248995,0.0002228446,0.0001418748,0.0000699954,0.01279419],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9901946,"threshold_uncertainty_score":0.9999611,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3022455442","doi":"10.1016/j.antiviral.2020.104816","title":"Mechanisms of HBV immune evasion","year":2020,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto General Hospital; Toronto Rehabilitation Institute; University of Toronto; University Health Network","funders":"","keywords":"Innate immune system; Acquired immune system; Immunology; Immunity; Immune system; Biology; Context (archaeology); Hepatitis B virus; Evasion (ethics); Virology; Virus","retraction":null,"screen_n_in":null,"score":{"opus":0.3115883086993262,"gpt":0.5095569659367478,"spread":0.1979686572374216,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001575414,0.0003050361,0.002618734,0.00047826,0.0001258681,0.00001705678,0.0003450743,0.00030594,0.00008033019],"category_scores_gemma":[0.002020318,0.0002228685,0.0006022548,0.001192939,0.0002730693,0.00005231512,0.0007334577,0.001383757,0.001566235],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001701019,"about_ca_system_score_gemma":0.0009123849,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005403825,"about_ca_topic_score_gemma":0.00003318708,"domain_scores_codex":[0.9961237,0.0006141067,0.0007259271,0.0004972977,0.001462996,0.0005760149],"domain_scores_gemma":[0.9981461,0.0005709452,0.0001648789,0.0005931563,0.0004329708,0.00009196674],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000289389,0.0000855988,0.00001107238,0.02388759,0.0002689944,0.0003088617,0.00005581694,3.84559e-10,0.0006961784,0.001747491,0.002318065,0.9705914],"study_design_scores_gemma":[0.0002362155,0.0008215398,0.00005237434,0.02421755,0.0003240306,0.00001935934,0.00002062473,0.000002823862,0.001129362,0.0003937087,0.9726086,0.0001737641],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001579292,0.986845,0.00003972343,0.0002324745,0.0001134046,0.001406699,0.00005038674,0.00003896648,0.01125756],"genre_scores_gemma":[0.003486256,0.9935929,0.0003129402,0.00001603594,0.000141243,0.00009418209,0.00006448298,0.0000818334,0.002210195],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9704176,"threshold_uncertainty_score":0.9992111,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2901227506","doi":"10.1016/j.antiviral.2018.11.011","title":"Tomatidine, a novel antiviral compound towards dengue virus","year":2018,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Mosquito-borne diseases and control","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Wageningen University and Research; Centers for Disease Control and Prevention; Bundesministerium für Bildung und Forschung; Deutsche Forschungsgemeinschaft; Universiteit Leiden; Leids Universitair Medisch Centrum; European Commission; Ministère de l'Économie, de la Science et de l'Innovation - Québec; University of South Carolina; Universitair Medisch Centrum Groningen; Universidad de Antioquia; Departamento Administrativo de Ciencia, Tecnología e Innovación (COLCIENCIAS); Rijksuniversiteit Groningen; Purdue University","keywords":"Dengue virus; Dengue fever; Virology; Virus; Antiviral drug; Biology; Serotype","retraction":null,"screen_n_in":null,"score":{"opus":0.09638298681734651,"gpt":0.4268996567500781,"spread":0.3305166699327315,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001098055,0.0002360141,0.0004466127,0.0003221854,0.0003667096,0.0001506653,0.0003526196,0.0001433468,0.0002604294],"category_scores_gemma":[0.000596846,0.0001939744,0.0002141349,0.000782591,0.0006505459,0.0002256798,0.0002766452,0.0005352939,0.001366057],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009777016,"about_ca_system_score_gemma":0.0004916572,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001165533,"about_ca_topic_score_gemma":0.0002041897,"domain_scores_codex":[0.9966084,0.0001643991,0.0003379933,0.0005821298,0.001293451,0.001013627],"domain_scores_gemma":[0.9981048,0.0001608354,0.00005322026,0.0006983554,0.0007765742,0.000206249],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.002042354,0.001808794,0.02297937,0.0002404072,0.0003166812,0.0006078997,0.0004868509,6.102342e-8,0.8046361,0.008106006,0.04901955,0.1097559],"study_design_scores_gemma":[0.01298623,0.005416593,0.5468536,0.00072429,0.000269892,0.0001488957,0.001047506,0.01168197,0.3126301,0.00132336,0.105824,0.001093577],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9381447,0.0003727615,0.0003974435,0.001590867,0.0002176574,0.0007032495,0.00006703081,0.0001115589,0.05839469],"genre_scores_gemma":[0.9925169,0.0000808494,0.0003692186,0.0005249035,0.001439017,0.00004995051,0.0000392044,0.00004987002,0.004930122],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5238742,"threshold_uncertainty_score":0.9994115,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3128621058","doi":"10.1016/j.antiviral.2021.105034","title":"Emerging antiviral therapeutics for human adenovirus infection: Recent developments and novel strategies","year":2021,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":79,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Lawson Health Research Institute; Western University","funders":"National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Antiviral therapy; Disease; Limiting; Medicine; Virology; Intensive care medicine; Virus; Outbreak; Immunology; Biology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.2334401548311417,"gpt":0.5003849075069242,"spread":0.2669447526757825,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002105184,0.0005312486,0.0009541005,0.0004214978,0.0007010201,0.0004155684,0.0005121197,0.0006117633,0.00001507128],"category_scores_gemma":[0.0001497638,0.0004880957,0.0003206995,0.0007530002,0.0003983258,0.00002173009,0.0006821458,0.0008892081,0.00002054063],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001119374,"about_ca_system_score_gemma":0.001955218,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004238176,"about_ca_topic_score_gemma":0.0003230003,"domain_scores_codex":[0.9957851,0.0006800882,0.0005803342,0.001119415,0.0007409222,0.001094196],"domain_scores_gemma":[0.9982442,0.0001434035,0.000153893,0.0006659705,0.0007007799,0.0000917355],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001476551,0.0001664064,0.00003278802,0.002301243,0.0006158545,0.00001128699,0.00003595668,1.410164e-7,0.02846709,0.0003872885,0.0004812492,0.967353],"study_design_scores_gemma":[0.0005886814,0.001575373,0.00001388015,0.001242918,0.00008466338,0.00001457742,0.00007951013,0.000002497016,0.01332548,0.00009564622,0.9824412,0.0005355454],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.005201579,0.9910039,0.0003110996,0.00005659507,0.0001659538,0.001515407,0.0001008395,0.00002287102,0.001621719],"genre_scores_gemma":[0.006426609,0.9897986,0.0002226268,0.00004001776,0.0005220544,0.0003740321,0.0008840904,0.0001500928,0.001581896],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.98196,"threshold_uncertainty_score":0.9997571,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3013944367","doi":"10.1016/j.antiviral.2020.104780","title":"Put a cork in it: Plugging the M2 viral ion channel to sink influenza","year":2020,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Simon Fraser University; University of British Columbia","funders":"National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research; National Institutes of Health; Health Research","keywords":"Virology; Virus; Adamantane; Influenza A virus; Pandemic; Biology; Chemistry; Coronavirus disease 2019 (COVID-19); Medicine; Infectious disease (medical specialty)","retraction":null,"screen_n_in":null,"score":{"opus":0.4645564701714462,"gpt":0.5617031123935495,"spread":0.09714664222210334,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005497074,0.0007265996,0.002695635,0.001714557,0.00059831,0.0002553558,0.001276395,0.0004806605,0.00004186122],"category_scores_gemma":[0.008759424,0.0004618883,0.000621303,0.004518658,0.0006868811,0.0002021784,0.002511367,0.005524174,0.00428326],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001025467,"about_ca_system_score_gemma":0.002044151,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006027949,"about_ca_topic_score_gemma":0.00014627,"domain_scores_codex":[0.9903954,0.001835598,0.001147644,0.001230537,0.003112927,0.002277878],"domain_scores_gemma":[0.9955359,0.002191764,0.0001564619,0.001169252,0.0005994405,0.0003472089],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004325377,0.0001446881,0.00007573281,0.01116063,0.0003243788,0.001302427,0.001623725,7.419097e-7,0.00005135306,0.0002783226,0.02680396,0.9578015],"study_design_scores_gemma":[0.0006849322,0.0008426537,0.0001167438,0.01950273,0.0001038621,0.00002559366,0.0003614528,0.00005342119,0.00003717018,0.00008825533,0.9777897,0.0003935103],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002887343,0.9779758,0.000005814044,0.004736769,0.0001771996,0.005830883,0.0000721023,0.00009109714,0.0108216],"genre_scores_gemma":[0.001536087,0.9919493,0.00004550319,0.001925622,0.001212595,0.001072003,0.00003546768,0.0001646824,0.002058728],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.957408,"threshold_uncertainty_score":0.9997833,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2770489650","doi":"10.1016/j.antiviral.2017.11.013","title":"Prevention and treatment of respiratory viral infections: Presentations on antivirals, traditional therapies and host-directed interventions at the 5th ISIRV Antiviral Group conference","year":2017,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Respiratory viral infections research","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; National Institute of Allergy and Infectious Diseases; National Cancer Institute; U.S. Department of Health and Human Services; National Institutes of Health; North Carolina Department of Health and Human Services; Foundation for the National Institutes of Health","keywords":"Favipiravir; Human metapneumovirus; Medicine; Nitazoxanide; Virology; Clinical trial; Respiratory tract infections; Immunology; Intensive care medicine; Respiratory system; Internal medicine; Coronavirus disease 2019 (COVID-19); Disease; Infectious disease (medical specialty)","retraction":null,"screen_n_in":null,"score":{"opus":0.3514624045679613,"gpt":0.4963894126311662,"spread":0.1449270080632049,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["sts"],"consensus_categories":["sts"],"category_scores_codex":[0.001511649,0.0003038428,0.0004887456,0.0006975624,0.002521012,0.000396653,0.0002552142,0.0001764977,0.0001121425],"category_scores_gemma":[0.0008957821,0.0002171621,0.000273632,0.0003737262,0.002937567,0.0007733931,0.0002901434,0.0005589478,0.00005592731],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001925432,"about_ca_system_score_gemma":0.0002371296,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005099339,"about_ca_topic_score_gemma":0.0008546349,"domain_scores_codex":[0.9960905,0.001167448,0.0005537963,0.0006606687,0.000968783,0.0005587849],"domain_scores_gemma":[0.9973152,0.0007896872,0.0002540509,0.0009734762,0.0005494162,0.0001181897],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002110858,0.006357847,0.5414411,0.0004654662,0.001161698,0.0001032952,0.001343627,7.589998e-7,0.2689948,0.04000489,0.004406577,0.133609],"study_design_scores_gemma":[0.00315108,0.01083256,0.9401252,0.0004559811,0.0001011707,0.00002734941,0.0003504885,0.0002010065,0.03871222,0.001667142,0.004137642,0.0002381996],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9854671,0.001292139,0.00005591094,0.001491462,0.0001176337,0.001836951,0.0001157237,0.00007187806,0.009551166],"genre_scores_gemma":[0.9919811,0.002311731,0.00006849309,0.00003677345,0.0001887108,0.0003708469,0.00004595871,0.00003917269,0.004957226],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.398684,"threshold_uncertainty_score":0.9997759,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2073480716","doi":"10.1016/j.antiviral.2014.03.017","title":"Use of FDA approved therapeutics with hNTCP metabolic inhibitory properties to impair the HDV lifecycle","year":2014,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Institut National de la Recherche Scientifique","funders":"Canadian Institutes of Health Research","keywords":"Hepatitis D virus; Virology; Hepatitis D; Viral entry; Medicine; Entry inhibitor; Hepatitis B virus; In vitro; Viral replication; Virus; Pharmacology; Biology; HBsAg","retraction":null,"screen_n_in":null,"score":{"opus":0.2238224942195481,"gpt":0.379732559637433,"spread":0.1559100654178849,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001401512,0.0001547915,0.0003794067,0.0001847516,0.0002269842,0.00005045542,0.000199081,0.00006048608,0.000005839666],"category_scores_gemma":[0.0009113466,0.00007825061,0.00005877996,0.0005927931,0.0006407462,0.0001417889,0.0002489006,0.000444772,0.0001117386],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003161632,"about_ca_system_score_gemma":0.000191758,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002683829,"about_ca_topic_score_gemma":0.00107583,"domain_scores_codex":[0.9974623,0.0004902528,0.0002407592,0.0002755562,0.0009973514,0.000533818],"domain_scores_gemma":[0.9982398,0.0004189863,0.00004433331,0.0005969869,0.0006230079,0.00007694],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001501511,0.000492047,0.3083688,0.0002762127,0.0005304368,0.00001636332,0.007067762,0.000004277776,0.6112946,0.001077664,0.009785968,0.05958436],"study_design_scores_gemma":[0.001041878,0.002961703,0.3542731,0.0003923895,0.0001048462,0.000006736424,0.0008267419,0.0007003692,0.5185485,0.00007450381,0.1208144,0.0002547572],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9927346,0.0006109882,0.00006149099,0.003497938,0.00004197278,0.0009394909,0.000005195786,0.00004060706,0.002067715],"genre_scores_gemma":[0.9956896,0.000309045,0.000351068,0.0008034876,0.0001972017,0.00009626779,0.000001437199,0.00003921433,0.002512687],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1110285,"threshold_uncertainty_score":0.4057164,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1982168548","doi":"10.1016/j.antiviral.2014.04.001","title":"E138A in HIV-1 reverse transcriptase is more common in subtype C than B: Implications for rilpivirine use in resource-limited settings","year":2014,"lang":"en","type":"article","venue":"Antiviral Research","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":68,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"AIDS Vancouver","funders":"National Institute of General Medical Sciences; National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research; World Health Organization","keywords":"Rilpivirine; Tenofovir; Emtricitabine; Reverse transcriptase; Virology; Human immunodeficiency virus (HIV); Reverse-transcriptase inhibitor; Biology; Genotype; Coinfection; Viral load; Medicine; Antiretroviral therapy; Genetics; Polymerase chain reaction; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.07436114394507591,"gpt":0.3682620816753785,"spread":0.2939009377303026,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002059599,0.0001789301,0.0003499386,0.0008951278,0.000170709,0.00003891372,0.0003642134,0.0002385146,0.00004539565],"category_scores_gemma":[0.000798041,0.0001634983,0.00008767055,0.0009640799,0.0003623785,0.0001935686,0.0001214338,0.0008828043,0.0004759772],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001611274,"about_ca_system_score_gemma":0.0001055511,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003126061,"about_ca_topic_score_gemma":0.006252283,"domain_scores_codex":[0.9969057,0.0009981706,0.0003825738,0.0005251957,0.0001070034,0.001081354],"domain_scores_gemma":[0.9980758,0.001201653,0.00003987905,0.0005329662,0.0001057523,0.0000439738],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001546996,0.0008790955,0.8094808,0.00007417167,0.00004268919,0.00004075928,0.001383244,0.000001685842,0.1285771,0.001225735,0.04611491,0.01063276],"study_design_scores_gemma":[0.006346453,0.0005952449,0.8400006,0.000178157,0.000007331206,0.000007558835,0.0005110645,0.00007309093,0.02188241,0.0006381008,0.1295291,0.0002309847],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9851201,0.0003279252,0.00002237963,0.0119476,0.0000234328,0.001124861,0.0005254647,0.00002373291,0.000884542],"genre_scores_gemma":[0.9950631,0.0001482344,0.00009410278,0.0002610684,0.00001445336,0.0003058357,0.00102389,0.00002676355,0.003062521],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1066947,"threshold_uncertainty_score":0.6667268,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1990365048","doi":"10.1016/j.antiviral.2006.01.006","title":"Treatment of respiratory virus infections","year":2006,"lang":"en","type":"review","venue":"Antiviral Research","topic":"Respiratory viral infections research","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval","funders":"","keywords":"Coronaviridae; Respiratory tract infections; Pneumonia; Virology; Paramyxoviridae; Biology; Virus; Respiratory system; Immunology; Respiratory disease; Viral disease; Medicine; Intensive care medicine; Coronavirus disease 2019 (COVID-19); Disease; Internal medicine; Lung; Infectious disease (medical specialty)","retraction":null,"screen_n_in":null,"score":{"opus":0.3792323570570513,"gpt":0.5594505361829851,"spread":0.1802181791259338,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001302122,0.0005509779,0.002558358,0.00332126,0.0003890073,0.00007195454,0.000306881,0.00071756,0.0001308677],"category_scores_gemma":[0.0006292473,0.0004057873,0.001194834,0.003620969,0.001355625,0.0001576968,0.0002001433,0.001366,0.001644948],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00131692,"about_ca_system_score_gemma":0.003073223,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001267836,"about_ca_topic_score_gemma":0.000149785,"domain_scores_codex":[0.9937201,0.001632262,0.001198657,0.0008385742,0.00157464,0.001035762],"domain_scores_gemma":[0.9961796,0.001030395,0.000238195,0.001483769,0.0008900425,0.0001779933],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004170375,0.002139895,0.0003444053,0.008331351,0.0003881015,0.0002907817,0.00001672645,8.147271e-8,0.0003725268,0.0004445807,0.005351419,0.9822784],"study_design_scores_gemma":[0.0006310588,0.005844504,0.0001015551,0.002887761,0.0003549412,0.00005900534,0.000009346536,0.000001899099,0.001024325,0.00003445333,0.9887925,0.0002585972],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0009753754,0.9430045,0.000007322154,0.00001586174,0.000135521,0.002842005,0.0001158489,0.00009005408,0.05281346],"genre_scores_gemma":[0.0007518078,0.9869101,0.00002871412,0.000006724034,0.0006654556,0.000735309,0.00011234,0.0001448938,0.01064463],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9834411,"threshold_uncertainty_score":0.9998394,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1995785316","doi":"10.1016/j.antiviral.2004.05.006","title":"The synergistic effects of betulin with acyclovir against herpes simplex viruses","year":2004,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Natural product bioactivities and synthesis","field":"Biochemistry, Genetics and Molecular Biology","cited_by":66,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; St. Paul's Hospital","funders":"","keywords":"Betulin; Herpes simplex virus; Vero cell; EC50; Cytotoxicity; Chemistry; Virology; Pharmacology; Microbiology; In vitro; Virus; Biology; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.0216731183844416,"gpt":0.3243221376922729,"spread":0.3026490193078313,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000504501,0.0001275217,0.000142483,0.00004668204,0.0002973608,0.00004693823,0.000325167,0.00009095547,9.297447e-7],"category_scores_gemma":[0.0007153783,0.00007425166,0.00006902352,0.0002097319,0.0006184204,0.000007497012,0.0001640374,0.0001706811,0.00001056315],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000182117,"about_ca_system_score_gemma":0.0001435706,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002117838,"about_ca_topic_score_gemma":0.0001737986,"domain_scores_codex":[0.9985751,0.0001826829,0.0001391499,0.000297565,0.0003826299,0.0004229],"domain_scores_gemma":[0.9990367,0.0002941881,0.00004879363,0.0004247282,0.0001589364,0.00003662728],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003043354,0.00007996199,0.0001724489,0.0000553951,0.00008113995,0.00001394526,0.00002894824,0.000007296723,0.932125,0.0005263746,0.0004825963,0.06612261],"study_design_scores_gemma":[0.0003586336,0.0004934152,0.001077368,0.00004498845,0.000007200047,8.893243e-7,0.0001182873,0.000002798758,0.9769561,0.0003523904,0.02047798,0.0001099869],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9963186,0.001594224,0.00006711359,0.0004887574,0.0000507331,0.000248053,0.000008578671,0.000007336452,0.001216549],"genre_scores_gemma":[0.9981154,0.0009363071,0.0001094589,0.00006859477,0.0001787545,0.00001866665,0.000009108703,0.00002111735,0.0005426457],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06601262,"threshold_uncertainty_score":0.3027895,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2304592771","doi":"10.1016/j.antiviral.2016.03.012","title":"Activity-based and fraction-guided analysis of Phyllanthus urinaria identifies loliolide as a potent inhibitor of hepatitis C virus entry","year":2016,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis C virus research","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"Taipei Medical University; Ministry of Science and Technology, Taiwan","keywords":"Hepatitis C virus; Virology; Hepatocellular carcinoma; Ribavirin; Hepatitis C; Medicine; Entry inhibitor; Viral entry; Virus; Viral replication; Cancer research","retraction":null,"screen_n_in":null,"score":{"opus":0.07069911098754443,"gpt":0.4157667169717684,"spread":0.3450676059842239,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001777824,0.0001934443,0.0007986084,0.002191821,0.0001375113,0.00004233075,0.0002035986,0.0001819813,0.0003061049],"category_scores_gemma":[0.002670782,0.0001427927,0.000266665,0.002109451,0.0008584484,0.0002673697,0.0002418127,0.0004152828,0.00009654264],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001900673,"about_ca_system_score_gemma":0.0005848216,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02351273,"about_ca_topic_score_gemma":0.001703113,"domain_scores_codex":[0.9956281,0.0006605336,0.0005273817,0.0005271542,0.002009167,0.0006476677],"domain_scores_gemma":[0.9966223,0.001299863,0.0001691953,0.0006642505,0.00104961,0.0001947321],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0008042333,0.0003840764,0.3508137,0.0001940552,0.0006726389,0.0001492806,0.00008529113,5.781677e-7,0.619427,0.0001056185,0.0009208127,0.02644282],"study_design_scores_gemma":[0.001137803,0.0006759305,0.3607485,0.0002891748,0.0001810535,0.000003502077,0.00003402904,0.0004968377,0.635768,0.0001249891,0.0004306443,0.0001095149],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9934382,0.0001620812,0.000270195,0.00101585,0.00005022603,0.0005320509,0.00016721,0.00002489165,0.004339259],"genre_scores_gemma":[0.9956607,0.002529572,0.0001065369,0.00003017167,0.00008635717,0.00004287574,0.0000172068,0.00003043463,0.001496203],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0263333,"threshold_uncertainty_score":0.9829898,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2016436352","doi":"10.1016/j.antiviral.2007.09.005","title":"Genistein treatment of cells inhibits arenavirus infection","year":2007,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Viral Infections and Outbreaks Research","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Infection and Immunity","funders":"National Institute of Allergy and Infectious Diseases; National Institutes of Health","keywords":"Arenavirus; Biology; Virology; Genistein; Viral envelope; Tyrosine kinase; Signal transduction; Virus; Lymphocytic choriomeningitis; Cell biology; In vitro; Biochemistry; Cytotoxic T cell","retraction":null,"screen_n_in":null,"score":{"opus":0.15465793012102,"gpt":0.4753572917764967,"spread":0.3206993616554767,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001399461,0.0001287803,0.0002777051,0.0007196509,0.0001896237,0.00002753118,0.00005246358,0.0001355046,0.00009247168],"category_scores_gemma":[0.000117438,0.00009915556,0.0001646769,0.001110438,0.0002864505,0.0001050258,0.00006185027,0.000315148,0.0004111256],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00027982,"about_ca_system_score_gemma":0.0001897114,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003633379,"about_ca_topic_score_gemma":0.0004731104,"domain_scores_codex":[0.9978312,0.0001324136,0.0003145232,0.0002846374,0.0007917234,0.0006455315],"domain_scores_gemma":[0.9987683,0.0002537541,0.00004008083,0.0003005926,0.0005081096,0.0001291344],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0004444088,0.0008700524,0.0277601,0.00006358791,0.00005252062,0.0001015204,0.0001524293,4.057154e-7,0.8289339,0.0002265017,0.0004856402,0.1409089],"study_design_scores_gemma":[0.001105361,0.003613891,0.05111594,0.00005416312,0.00001483561,0.00002176454,0.00007392113,0.00005747688,0.9326636,0.00007866006,0.01112133,0.00007910572],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9597119,0.0001750313,0.0002053167,0.0001395366,0.00009301704,0.000556723,0.000007767728,0.00003678921,0.03907393],"genre_scores_gemma":[0.9900571,0.0007433159,0.000138458,0.00001295133,0.0002340537,0.00001717519,0.00001131206,0.00002255662,0.008763084],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1408298,"threshold_uncertainty_score":0.5492606,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2070528933","doi":"10.1016/j.antiviral.2009.05.004","title":"Translational insensitivity to potent activation of PKR by HCV IRES RNA","year":2009,"lang":"en","type":"article","venue":"Antiviral Research","topic":"RNA regulation and disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":64,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba","funders":"National Institute of Allergy and Infectious Diseases; National Institute of General Medical Sciences; National Institutes of Health","keywords":"Internal ribosome entry site; Protein kinase R; RNA; Biology; Translation (biology); EIF-2 kinase; Virology; Eukaryotic translation; Protein biosynthesis; Picornavirus; Interferon; Molecular biology; Ribosome; RNA silencing; Initiation factor; Messenger RNA; Phosphorylation; Cell biology; RNA interference; Biochemistry; Protein kinase A; Gene","retraction":null,"screen_n_in":null,"score":{"opus":0.03611876428698934,"gpt":0.3623040886127023,"spread":0.326185324325713,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003052166,0.00006234778,0.00007089783,0.00007767215,0.00006758815,0.00001590606,0.00008124186,0.00006404994,0.000007516612],"category_scores_gemma":[0.000155088,0.00005970043,0.0000504545,0.000176981,0.00005743299,0.000007731986,0.00002330444,0.00006490022,0.00001198666],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000008144424,"about_ca_system_score_gemma":0.00007997214,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003215966,"about_ca_topic_score_gemma":0.000005094068,"domain_scores_codex":[0.9990409,0.000118936,0.000113931,0.0001924569,0.0003561457,0.0001776212],"domain_scores_gemma":[0.9995547,0.00002103156,0.00002148338,0.000155102,0.0001868811,0.00006080827],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002490679,0.0001117255,0.0009964337,0.000004141194,0.000006529935,9.96049e-7,0.00002294842,0.00001593254,0.9480635,0.000358407,0.009366163,0.04080414],"study_design_scores_gemma":[0.0002911623,0.000264452,0.123671,0.000009682673,0.000001648976,3.694573e-7,0.00002000903,0.0001294685,0.8711191,0.0003476308,0.004071551,0.000073935],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9902368,0.00005320128,0.00151718,0.002941365,0.00001279282,0.0001588246,0.00002521576,0.00000497055,0.005049657],"genre_scores_gemma":[0.9984539,0.00001820485,0.0001402365,0.0002300709,0.00006485292,0.000003110063,0.0001164873,0.000005363073,0.0009677863],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1226746,"threshold_uncertainty_score":0.2434513,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2915009094","doi":"10.1016/j.antiviral.2019.02.009","title":"Inhibition of HBsAg secretion by nucleic acid polymers in HepG2.2.15 cells","year":2019,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Institut National de la Recherche Scientifique","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"HBsAg; In vitro; Secretion; Nucleic acid; Immune system; Hepatitis B virus; Hepatocellular carcinoma; Cirrhosis; Chemistry; Virology; Biology; Medicine; Immunology; Cancer research; Biochemistry; Virus; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.04038057639909725,"gpt":0.3535649606924945,"spread":0.3131843842933972,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009501841,0.0001060717,0.0003017571,0.000364819,0.00004858795,0.00001204564,0.00007266904,0.0001095459,0.0003901378],"category_scores_gemma":[0.0001932822,0.00009835848,0.00006053528,0.0006579195,0.0002105757,0.000157525,0.0001162236,0.0004329129,0.0008357696],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001311234,"about_ca_system_score_gemma":0.0001077689,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003207504,"about_ca_topic_score_gemma":0.0004377418,"domain_scores_codex":[0.9979641,0.0002165849,0.0002717511,0.0002787264,0.0007997543,0.0004691215],"domain_scores_gemma":[0.999347,0.0001297001,0.00004542623,0.0002507964,0.0001768192,0.00005028575],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001688485,0.0001340768,0.0928276,0.0001395436,0.00001641215,0.00002238581,0.0004655835,6.864766e-8,0.8975874,0.00008839915,0.004066245,0.004483506],"study_design_scores_gemma":[0.001313066,0.0008655853,0.06126854,0.0004088524,0.000007449328,0.000001682166,0.0004442775,0.0001757254,0.9337344,0.0001070438,0.001554401,0.0001189798],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9689207,0.0004519669,0.000005009976,0.0006129087,0.00006777285,0.0005299402,0.00002510974,0.00001865977,0.02936793],"genre_scores_gemma":[0.9956593,0.0006378107,0.00004220351,0.00008554652,0.00003998499,0.00001486937,0.00003463207,0.00002301232,0.003462646],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03614706,"threshold_uncertainty_score":0.9999422,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2086933325","doi":"10.1016/j.antiviral.2007.08.008","title":"Activity of the neuraminidase inhibitor A-315675 against oseltamivir-resistant influenza neuraminidases of N1 and N2 subtypes","year":2007,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval","funders":"","keywords":"Oseltamivir; Neuraminidase; Neuraminidase inhibitor; Virology; Influenza A virus; Recombinant DNA; Microbiology; Mutant; Biology; Influenza A virus subtype H5N1; Zanamivir; Virus; Medicine; Gene; Genetics; Coronavirus disease 2019 (COVID-19); Internal medicine; Infectious disease (medical specialty)","retraction":null,"screen_n_in":null,"score":{"opus":0.1371009898528008,"gpt":0.4384835129207547,"spread":0.3013825230679539,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003806141,0.0002575736,0.0006135576,0.0005337037,0.0003387694,0.0000353695,0.0003579766,0.0001668022,0.000009383825],"category_scores_gemma":[0.00600849,0.0001714216,0.0001785629,0.001348251,0.002567438,0.0002369465,0.0008370066,0.001044975,0.00001548918],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000913781,"about_ca_system_score_gemma":0.0003780547,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005480548,"about_ca_topic_score_gemma":0.0002078221,"domain_scores_codex":[0.9954212,0.0004978754,0.0005915038,0.0004785798,0.002044608,0.0009662276],"domain_scores_gemma":[0.9955755,0.002238548,0.0001913908,0.0007915531,0.001048574,0.0001544754],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002694209,0.0004333826,0.1445612,0.0005859241,0.0001101652,0.0000848648,0.0004580924,3.821266e-7,0.8223251,0.0002613176,0.000614848,0.02787062],"study_design_scores_gemma":[0.0009539527,0.0006812809,0.4790879,0.0002276515,0.00002051637,0.000003013677,0.0003324678,0.00003277775,0.5170799,0.00003984294,0.001444005,0.00009669582],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9917416,0.000986919,0.000004095323,0.0004261298,0.00007207314,0.0009338098,0.00006552233,0.00002468331,0.005745178],"genre_scores_gemma":[0.9986293,0.0003617482,0.00005818295,0.0001788965,0.0001202032,0.00001577895,0.00000220345,0.00003616092,0.0005975168],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3345267,"threshold_uncertainty_score":0.9459834,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2074366047","doi":"10.1016/j.antiviral.2006.10.012","title":"Characterization of drug-resistant recombinant influenza A/H1N1 viruses selected in vitro with peramivir and zanamivir","year":2006,"lang":"en","type":"article","venue":"Antiviral Research","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre hospitalier de l'Université Laval; Université Laval","funders":"","keywords":"Zanamivir; Neuraminidase; Virology; Neuraminidase inhibitor; Oseltamivir; Virus; Influenza A virus; Mutation; Recombinant DNA; Hemagglutinin (influenza); Recombinant virus; Biology; Influenzavirus B; Orthomyxoviridae; Gene; Genetics; Medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.0685784773872101,"gpt":0.3846492807348781,"spread":0.316070803347668,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001422776,0.0002313783,0.0005618019,0.0009354831,0.0002063833,0.00005945223,0.0001527547,0.000102128,0.0000101891],"category_scores_gemma":[0.000602178,0.000176151,0.0000434007,0.001996354,0.0007406859,0.0003058866,0.0001966599,0.0006989892,0.00002173138],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001743909,"about_ca_system_score_gemma":0.0003922684,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003514825,"about_ca_topic_score_gemma":0.0008054,"domain_scores_codex":[0.9964914,0.000428319,0.0005049968,0.0004862901,0.001221807,0.0008671534],"domain_scores_gemma":[0.9981397,0.0003580571,0.00009838074,0.0003553867,0.0009754254,0.0000730286],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.004280685,0.0003592416,0.1317621,0.0002568761,0.000047341,0.0001062921,0.0003220531,3.33938e-7,0.8602155,0.0002257606,0.000103509,0.002320223],"study_design_scores_gemma":[0.00208399,0.0005291168,0.56012,0.0002516539,0.00001244991,0.000004956543,0.0001547568,0.0001342556,0.4353392,0.00006471227,0.001166175,0.0001387484],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962853,0.0004322728,0.000007146339,0.0003074649,0.00001850637,0.000955618,0.00003452827,0.00004061331,0.001918588],"genre_scores_gemma":[0.9983078,0.000317885,0.0001636688,0.00009156312,0.00005377136,0.00008011498,0.00004128483,0.00004368317,0.0009002834],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4283579,"threshold_uncertainty_score":0.7183229,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1978815542","doi":"10.1016/j.antiviral.2007.06.010","title":"Protease inhibitor resistance in HIV-infected patients: Molecular and clinical perspectives","year":2007,"lang":"en","type":"review","venue":"Antiviral Research","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Ritonavir; Drug resistance; Protease; Protease inhibitor (pharmacology); Virology; Biology; Drug; Human immunodeficiency virus (HIV); Virus; Genetics; Viral load; Pharmacology; Antiretroviral therapy; Enzyme","retraction":null,"screen_n_in":null,"score":{"opus":0.1083616495597315,"gpt":0.4797336593086232,"spread":0.3713720097488917,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002233201,0.0003846716,0.001478752,0.0009667405,0.00009915449,0.00005076695,0.0001429876,0.0004137239,0.00001752478],"category_scores_gemma":[0.001933362,0.0002860446,0.0002969886,0.00123536,0.0004247485,0.00008801033,0.0002208185,0.00158506,0.000257485],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004852426,"about_ca_system_score_gemma":0.0009177675,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001424753,"about_ca_topic_score_gemma":0.00004895404,"domain_scores_codex":[0.9956917,0.0009009865,0.0008358773,0.0008892019,0.0009697229,0.0007125473],"domain_scores_gemma":[0.9982046,0.0006356153,0.0001256045,0.0004277754,0.0004198603,0.0001865205],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005334709,0.003313187,0.0411296,0.01139503,0.0005536499,0.003253065,0.0005679943,6.229914e-10,0.000002227997,0.0007791353,0.006027055,0.9324456],"study_design_scores_gemma":[0.003088114,0.0003895482,0.005169907,0.02361835,0.0002531664,0.000005457566,0.0001474784,6.245551e-7,0.00002455407,0.00005797214,0.9668276,0.0004172318],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01095071,0.9779668,0.00000430089,0.000271536,0.00004427069,0.003823974,0.00002400267,0.00003625239,0.006878161],"genre_scores_gemma":[0.003411733,0.9824776,0.0007672261,0.00001063276,0.0001352781,0.0001800157,0.0001842068,0.00006696704,0.01276635],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9608005,"threshold_uncertainty_score":0.9999592,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}